Zentek Ltd (ZEN)

Zentek Granted U.S. Patent for ZenGUARD(TM) Graphene-Based TechnologyJune 9, 2026 11:11 AM
NewsfileU.S. Patent No. 12,616,206 granted to Zentek with 327-day term extension; complements issued Canadian patent covering ZenGUARD(TM) in HVAC and PPE applications.Guelph, Ontario--(Newsfile Corp. - June 9, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") is pleased to announce that the United States Patent and Trademark Office has issued U.S. Patent No. 12,616,206 (the "Patent") covering the foundational graphene-based technology underlying the Company's ZenGUARD™ platform.The Patent includes a 327-day extension to its enforceable term to compensate for examination delays. The Patent is owned by Zentek Ltd., with Dr. Seyyedarash Haddadi named as lead inventor alongside co-inventors. The Patent further strengthens the Company's intellectual property protection for ZenGUARD™, complementing its issued Canadian patent covering personal protective equipment and heating, ventilation and air conditioning ("HVAC") applications, including ZenGUARD™ Enhanced Air Filters, which the Company announced on May 6, 2026, are now available for sale in Canada. U.S. Air Filtration MarketThe U.S. is among the largest markets globally for HVAC air filtration and is several times the size of the Canadian market. The U.S. air filter market was estimated at approximately US$5.3 billion in 2025¹.HVAC operations are a significant component of commercial building energy use, and industry estimates indicate approximately 30% of HVAC energy consumption is attributable to overcoming the resistance imposed by air filters². ZenGUARD™ Enhanced Air Filters are a graphene-based technology engineered to help address this problem by delivering enhanced air quality without imposing an energy penalty. The Company will continue evaluating U.S. regulatory requirements, including EPA registration, while working alongside its U.S. manufacturing and distribution partner, Quality Filters Inc., an established American air filter manufacturer headquartered in Robertsdale, Alabama, to potentially enter the U.S. market. Any such U.S. market entry remains subject to applicable regulatory requirements, commercial readiness, manufacturing and distribution considerations, market acceptance and other risks, and there can be no assurance that Zentek will enter the U.S. market, or as to the timing, scope or commercial success of any such entry.The U.S. patent grant broadens Zentek's intellectual property portfolio across its graphene-based and advanced material platforms, which underpin the ZenGUARD™ and Triera businesses. Each issued patent extends both the duration and geographic scope of protection for technologies the Company is advancing toward commercialization. Management Commentary"The U.S. and Canadian patents now protect ZenGUARD™'s underlying graphene-based indoor air quality technology in our two priority geographies," said Mohammed (Moe) Jiwan, Chief Executive Officer of Zentek. "ZenGUARD™ was developed in response to a specific market need: air filtration that materially improves indoor air quality in commercial and institutional buildings without imposing an energy penalty. We will continue to advance ZenGUARD™ alongside Quality Filters Inc. as the U.S. regulatory pathway clarifies."About Zentek Ltd.
Zentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. The Company's core platforms are Albany Graphite, ZenGUARD™, and Triera. Albany is the Company's principal critical minerals asset and is advancing toward a Preliminary Economic Assessment targeted for completion in the Summer of 2026.Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.References (public)https://www.mordorintelligence.com/industry-reports/north-america-air-filter-markethttps://cleanair.camfil.us/2025/03/19/hvac-engineers-resource-for-low-pressure-drop-air-filters/For more information:
Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: mjiwan2@zentek.com
W: www.zentek.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/300744 Original: Zentek Granted U.S. Patent for ZenGUARD(TM) Graphene-Based Technology

Zentek Announces Closing of Fully Subscribed Brokered LIFE Offering for Gross Proceeds of C$18 MillionMay 27, 2026 9:09 AM
NewsfileGuelph, Ontario--(Newsfile Corp. - May 27, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") is pleased to announce the closing of its previously announced "best efforts" private placement (the "Offering") for gross proceeds of C$18,000,000, which includes the exercise in full of the agent's option. Pursuant to the Offering, the Company sold 18,000,000 units of the Company (the "Units") at a price of C$1.00 per Unit (the "Offering Price"). Red Cloud Securities Inc. ("Red Cloud") acted as sole agent and bookrunner in connection with the Offering."Closing this financing reflects confidence in the value-creation path we have built across Albany Graphite, ZenGUARD™, and Triera since December," said Mohammed Jiwan, Chief Executive Officer of Zentek. "With the financing in place, we are well-capitalized to advance our near-term priorities, the Albany Preliminary Economic Assessment, ZenGUARD™ commercialization, and our critical minerals development work, with discipline and focus."Each Unit consists of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant"). Each Warrant entitles the holder thereof to purchase one Common Share (a "Warrant Share") at a price of C$1.50 at any time on or before May 27, 2029.The Company intends to use the net proceeds from the Offering for (i) the development and derisking of the Albany Graphite Project, including the completion of a new Preliminary Economic Assessment currently being prepared by Micon International Limited, the advancement of subsequent preliminary feasibility study work, and business development activities targeting small modular reactor developers, national defence end-users, and other high-intensity end-user markets for which Albany ultra-high-purity graphite is suited; (ii) the continued commercialization of the Company's ZenGUARD™ platform; (iii) payment obligations; and (iv) general working capital and corporate purposes.In accordance with National Instrument 45-106 – Prospectus Exemptions ("NI 45-106"), the Units were issued to Canadian purchasers pursuant to the listed issuer financing exemption under Part 5A of NI 45-106, as amended by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. The Common Shares and Warrants underlying the Units sold to Canadian purchasers (other than the Insiders), and the Warrant Shares underlying such Warrants, if exercised, are immediately freely tradeable in accordance with applicable Canadian securities legislation. The Units were also sold in the United States or to, or for the account or benefit of, U.S. persons, by way of private placement pursuant to exemptions from the registration requirements provided for under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), and in jurisdictions outside of Canada and the United States on a private placement or equivalent basis, in each case in accordance with all applicable laws, provided that no prospectus, registration statement, or other similar document is required to be filed in such jurisdiction. The Units issued to purchasers outside of Canada were issued pursuant to the exemption from the prospectus requirements in Canada available under OSC Rule 72-503 – Distributions Outside of Canada, and the securities issued from the sale of such Units are not subject to a four-month hold period in Canada.An offering document (the "Offering Document") dated May 14, 2026, related to the Offering can be accessed under the Company's profile on SEDAR+ at www.sedarplus.ca and on the Company's website at www.zentek.com.Certain directors and officers of the Company (the "Insiders") participated in the Offering for an aggregate of 695,000 Units, which constitutes "related party transactions" as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101"). Such related party transactions are exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of securities being issued to a related party nor the consideration being paid by a related party exceeds 25% of the Company's market capitalization. The participants in the Offering and the extent of such participation were not finalized until shortly prior to the completion of the Offering. Accordingly, it was not possible to publicly disclose details of the nature and extent of related party participation in the Offering pursuant to a material change report filed at least 21 days prior to the completion of the Offering.The Common Shares and Warrants underlying the Units sold the Insiders, and the Warrant Shares underlying such Warrants, if exercised, are subject to a hold period until September 28, 2026, as required by the TSX Venture Exchange.As consideration for their services, Red Cloud received a cash fee of C$1,197,360 and were issued 1,197,360 non-transferable common share purchase warrants (the "Broker Warrants"). Each Broker Warrant is exercisable into one Common Share at the Offering Price at any time on or before May 27, 2029. The Broker Warrants and any Common Shares issuable upon any future exercise of the Broker Warrants will be subject to a hold period in Canada in accordance with applicable Canadian securities law, expiring on September 28, 2026.The closing of the Offering remains subject to the final approval of the TSX Venture Exchange. The securities have not been, and will not be, registered under the U.S. Securities Act, or any U.S. state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or U.S. persons, absent registration under the U.S. Securities Act and all applicable U.S. state securities laws or in compliance with an exemption therefrom. This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful.About Zentek Ltd.Zentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. The Company's core platforms are Albany Graphite, ZenGUARD™, and Triera. The Albany Graphite Project is the Company's principal critical minerals asset and is advancing toward a new Preliminary Economic Assessment targeted for completion in Summer 2026.Recently, the Company has advanced its platforms through independent technical validation of Albany graphite meeting the threshold for nuclear, defence, aerospace, and premium lithium-ion battery applications; the revised regulatory classification by Health Canada confirming that ZenGUARD™ Enhanced Air Filters are not subject to regulation under the Pest Control Products Act; the addition of ZenGUARD™ Enhanced Air Filters to the Innovative Solutions Canada Pathway to Commercialization source list; the initiation of a U.S. commercial pilot program for ZenGUARD™ with Quality Filters Inc.; and the engagement of Micon International Limited, AppEco Inc., American Energy Technologies Company, and ERM Consultants Canada Ltd. to advance the new Preliminary Economic Assessment and supporting environmental baseline program at the Albany Graphite Project.Forward-Looking StatementsNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.This news release contains forward-looking statements. These statements, referred to herein as "forward-looking statements," are not historical facts, are made as of the date of this news release and include, without limitation, statements regarding the intended use of proceeds of the Offering, the Company's capitalization and ability to advance its near-term priorities, and the final approval of the Offering from the TSX Venture Exchange. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.For more information:Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: mjiwan2@zentek.com
W: www.zentek.comTHIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/299042 Original: Zentek Announces Closing of Fully Subscribed Brokered LIFE Offering for Gross Proceeds of C$18 Million

Zentek Announces That Its Brokered LIFE Offering Is Oversubscribed and Fully AllocatedMay 19, 2026 7:30 AM
NewsfileTHIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESGuelph, Ontario--(Newsfile Corp. - May 19, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") today announced that, further to its news release dated May 14, 2026, its previously announced "best efforts" marketed private placement (the "Marketed Offering") is oversubscribed and fully allocated. Pursuant to the Marketed Offering, the Company intends to raise gross proceeds of up to C$15,000,000 from the sale of up to 15,000,000 units of the Company (each, a "Unit") at a price of C$1.00 per Unit (the "Offering Price"). Red Cloud Securities Inc. ("Red Cloud") is acting as sole agent and bookrunner in connection with the Offering."The level of interest in this Offering reflects the institutional confidence in the value-creation path we have built across Albany Graphite, ZenGUARD™, and Triera over the past six months," said Mohammed Jiwan, Chief Executive Officer of Zentek. "This capital allows us to execute on the next 24 months of our plan with discipline and focus."Each Unit will consist of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant"). Each Warrant will entitle the holder thereof to purchase one Common Share (a "Warrant Share") at a price of C$1.50 at any time on or before the date that is 36 months following the Closing Date (as herein defined).The Company has granted Red Cloud an option, exercisable in whole or in part up to 48 hours prior to the closing of the Marketed Offering, to sell up to an additional 3,000,000 Units at the Offering Price for additional gross proceeds of up to C$3,000,000 (the "Agent's Option"). The Marketed Offering and the securities issuable on exercise of the Agent's Option are collectively referred to as the "Offering".Use of ProceedsAs disclosed in the offering document dated May 14, 2026 (the "Offering Document"), the Company intends to use the net proceeds from the Offering for (i) the development and derisking of the Albany Graphite Project, including the completion of a new Preliminary Economic Assessment currently being prepared by Micon International Limited, the advancement of subsequent preliminary feasibility study work, and business development activities targeting small modular reactor developers, national defence end-users, and other high-intensity end-user markets for which Albany ultra-high-purity graphite is suited; (ii) the continued commercialization of the Company's ZenGUARD™ platform; and (iii) payment of obligations, general working capital and corporate purposes.Listed Issuer Financing ExemptionThe Units are being offered for sale to purchasers resident in the provinces of British Columbia, Alberta, Manitoba, Saskatchewan, and Ontario pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 - Prospectus Exemptions, as amended by Coordinated Blanket Order 45-935 - Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. The common shares and warrants comprising the Units, and the common shares issuable on exercise of the warrants, are expected to be immediately freely tradeable in accordance with applicable Canadian securities legislation if sold to purchasers resident in Canada.The Units may also be sold in the United States or to, or for the account or benefit of, U.S. persons, by way of private placement pursuant to exemptions from the registration requirements provided for under the United States Securities Act of 1933, as amended, and in jurisdictions outside of Canada and the United States on a private placement or equivalent basis, in each case in accordance with all applicable laws.The Offering Document can be accessed under the Company's profile on SEDAR+ at www.sedarplus.ca and on the Company's website at www.zentek.com. Prospective investors should read the Offering Document before making an investment decision. The Offering is anticipated to close on or about May 27, 2026, or such other date as the Company and Red Cloud may agree (the "Closing Date"). Completion of the Offering is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the approval of the TSX Venture Exchange.About Zentek Ltd.
Zentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. The Company's core platforms are Albany Graphite, ZenGUARD™, and Triera. Albany is the Company's principal critical minerals asset and is advancing toward a Preliminary Economic Assessment targeted for completion in Summer 2026.Forward-Looking Statements
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.This news release contains forward-looking statements. These statements, referred to herein as "forward-looking statements", are not historical facts, are made as of the date of this news release and include, without limitation, statements regarding the completion and terms of the Offering, the anticipated closing date of the Offering, the intended use of proceeds of the Offering, and the approval of the Offering from the TSX Venture Exchange. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.For more information:
Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: mjiwan2@zentek.com
W: www.zentek.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/297891 Original: Zentek Announces That Its Brokered LIFE Offering Is Oversubscribed and Fully Allocated

Zentek Announces Brokered LIFE Offering for Gross Proceeds of up to C$15 MillionMay 14, 2026 4:30 PM
NewsfileGuelph, Ontario--(Newsfile Corp. - May 14, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") today announced that it has entered into an engagement agreement with Red Cloud Securities Inc. ("Red Cloud") to act as sole agent and bookrunner on a "best efforts" basis in connection with a marketed private placement (the "Marketed Offering") for gross proceeds of up to C$15,000,000 from the sale of up to 15,000,000 units of the Company (the "Units") at a price of C$1.00 per Unit (the "Offering Price").Each Unit will consist of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant"). Each Warrant will entitle the holder thereof to purchase one Common Share (a "Warrant Share") at a price of C$1.50 at any time on or before the date that is 36 months following the Closing Date (as herein defined).The Company has granted Red Cloud an option, exercisable in whole or in part up to 48 hours prior to the closing of the Marketed Offering, to sell up to an additional 3,000,000 Units at the Offering Price for additional gross proceeds of up to C$3,000,000 (the "Agent's Option"). The Marketed Offering and the securities issuable on exercise of the Agent's Option are collectively referred to as the "Offering".Use of ProceedsThe Company intends to use the net proceeds from the Offering for (i) the development and derisking of the Albany Graphite Project, including the completion of a new Preliminary Economic Assessment currently being prepared by Micon International Limited, the advancement of subsequent preliminary feasibility study work, and business development activities targeting small modular reactor developers, national defence end-users, and other high-intensity end-user markets for which Albany ultra-high-purity graphite is suited; (ii) the continued commercialization of the Company's ZenGUARD™ platform; and (iii) payment obligations, general working capital and corporate purposes.Listed Issuer Financing ExemptionSubject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 - Prospectus Exemptions ("NI 45-106"), the Units will be offered for sale to purchasers resident in the provinces of British Columbia, Alberta, Manitoba, Saskatchewan, and Ontario pursuant to the listed issuer financing exemption under Part 5A of NI 45-106, as amended by Coordinated Blanket Order 45-935 - Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. The Common Shares and Warrants underlying the Units, and the Warrant Shares underlying the Warrants, if exercised, are expected to be immediately freely tradeable in accordance with applicable Canadian securities legislation if sold to purchasers resident in Canada. The Units may also be sold in the United States or to, or for the account or benefit of, U.S. persons, by way of private placement pursuant to exemptions from the registration requirements provided for under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), and in jurisdictions outside of Canada and the United States on a private placement or equivalent basis, in each case in accordance with all applicable laws, provided that no prospectus, registration statement, or other similar document is required to be filed in such jurisdiction. The Units will be offered to purchasers outside of Canada pursuant to the exemption from the prospectus requirements in Canada available under OSC Rule 72-503 - Distributions Outside of Canada, and the securities issued from the sale of Units to purchasers outside of Canada are not expected to be subject to a four-month hold period in Canada.An offering document (the "Offering Document") dated May 14, 2026 related to the Offering can be accessed under the Company's profile on SEDAR+ at www.sedarplus.ca and on the Company's website at www.zentek.com. Prospective investors should read the Offering Document before making an investment decision.ClosingThe Offering is anticipated to close on or about May 27, 2026, or such other date as the Company and Red Cloud may agree (the "Closing Date"). Completion of the Offering is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the approval of the TSX Venture Exchange.Securities DisclaimerThe securities have not been, and will not be, registered under the U.S. Securities Act, or any U.S. state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or U.S. persons, absent registration under the U.S. Securities Act and all applicable U.S. state securities laws or in compliance with an exemption therefrom. This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or, or sale would be unlawful.About Zentek Ltd.Zentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. The Company's core platforms are AlbanyGraphite, ZenGUARD™, and Triera. The Albany Graphite Project is the Company's principal critical minerals asset and is advancing toward a new Preliminary Economic Assessment targeted for completion in Summer 2026.Since the appointment of Mohammed Jiwan as Chief Executive Officer effective December 1, 2025, the Company has advanced its platforms through independent technical validation of Albany graphite meeting the threshold for nuclear, defence, aerospace, and premium lithium-ion battery applications; the revised regulatory classification by Health Canada confirming that ZenGUARD™ Enhanced Air Filters are not subject to regulation under the Pest Control Products Act; the addition of ZenGUARD™ Enhanced Air Filters to the Innovative Solutions Canada Pathway to Commercialization source list; the initiation of a U.S. commercial pilot program for ZenGUARD™ with Quality Filters Inc.; and the engagement of Micon International Limited, AppEco Inc., American Energy Technologies Company, and ERM Consultants Canada Ltd. to advance the new Preliminary Economic Assessment and supporting environmental baseline program at the Albany Graphite Project.Forward-Looking StatementsNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.This news release contains forward-looking statements. These statements, referred to herein as "forward-looking statements", are not historical facts, are made as of the date of this news release and include, without limitation, statements regarding the completion and terms of the Offering, the anticipated closing date of the Offering, the intended use of proceeds of the Offering, and the approval of the Offering from the TSX Venture Exchange. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.For more information:Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: mjiwan@zentek.com
W: www.zentek.comTHIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/297560 Original: Zentek Announces Brokered LIFE Offering for Gross Proceeds of up to C$15 Million

Zentek's ZenGUARD(TM) Enhanced Air Filters Now Available for Direct Procurement by All Federal Departments and AgenciesMay 13, 2026 7:35 AM
NewsfileCulmination of multi-year Innovative Solutions Canada and National Research Council collaboration establishes Zentek as an exclusive supplier of this type of innovation to the Government of CanadaGuelph, Ontario--(Newsfile Corp. - May 13, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") is pleased to announce that Innovative Solutions Canada ("ISC") has added ZenGUARD™ Enhanced Air Filters to its Pathway to Commercialization ("PTC") source list. This step establishes Zentek as an exclusive supplier within the PTC framework of this type of innovation to the Government of Canada, administered through ISC, for a three-year period, during which any federal department or agency may purchase ZenGUARD™ Enhanced Air Filters directly.1 The milestone is the culmination of a multi-year collaboration between Zentek, ISC, and the National Research Council of Canada ("NRC").A National Challenge, AnsweredIndoor air quality became a national priority during the pandemic, particularly in federal buildings, schools, and public spaces where improving filtration without consuming more energy or replacing existing heating, ventilation, and air conditioning ("HVAC") infrastructure presented a significant technical challenge. To help address this need, Zentek was awarded a contract under the ISC Testing Stream - a standing open call for innovative Canadian prototypes - to validate ZenGUARD™ Enhanced Air Filters with the NRC.The NRC conducted rigorous validation testing in a purpose-built simulated classroom environment designed to replicate the most challenging real-world conditions. The results, as profiled by Innovation, Science and Economic Development Canada ("ISED"), showed that ZenGUARD™ increased viral filtration efficiency of a standard MERV 8 filter by approximately fivefold in a single air exchange, via a physical mechanism, with no measurable impact to airflow or energy consumption.Four Operational Outcomes in a Single Drop-in ProductZenGUARD™ Enhanced Air Filters deliver four operational outcomes through a single drop-in product:Safer indoor airLower HVAC energy consumption and associated emissionsLonger service intervals that reduce total cost of ownershipLess waste sent to the landfillBeyond NRC validation, the underlying performance is documented in three peer-reviewed ASHRAE publications and meets ASHRAE Standard 52.2 and ASHRAE Standard 241 testing requirements. ZenGUARD™ is manufactured in Guelph, Ontario and ZenGUARD™ Enhanced Air Filters are currently available for sale in Canada. The underlying technology is patented in Canada with applications filed in over 40 additional jurisdictions.Direct Alignment with the Greening Government StrategyZenGUARD™'s four operational outcomes are aligned with objectives under the federal Greening Government Strategy. Lower HVAC energy consumption can support reduced Scope 2 greenhouse gas emissions, consistent with the Government of Canada's commitment to reduce absolute Scope 1 and Scope 2 emissions by 40 percent by 2025 and at least 90 percent below 2005 levels by 2050. Longer filter service intervals reduce operational waste generated by federal real property operations, contributing to the federal target of diverting at least 75 percent of operational waste from landfills by 2030.2 Safer indoor air supports occupant health and well-being objectives identified under the Canada Green Buildings Strategy. ZenGUARD™ Enhanced Air Filters allow federal agencies to advance multiple greening commitments simultaneously through a single, easy-to-implement drop-in product decision.Available Now to Every Federal DepartmentZenGUARD™ Enhanced Air Filters are available for direct purchase by any Government of Canada department or agency for a period of three years. Potential users include, but are not limited to, the large real property portfolios managed by Public Services and Procurement Canada's Real Property and Portfolio Management Branch, as well as facilities operated by ISED and the NRC. The full PTC source list, which will include ZenGUARD™ Enhanced Air Filters, is available at: https://ised-isde.canada.ca/site/innovative-solutions-canada/en/pathway-commercializationInclusion on the PTC source list does not guarantee a minimum number of orders or contracts, and procurement decisions remain at the discretion of individual federal departments and agencies.Beyond Federal ProcurementZenGUARD™ Enhanced Air Filters are also available to provincial and municipal governments, public and private healthcare systems, commercial real estate operators, educational institutions, and international institutional buyers seeking validated indoor air quality solutions. Management Commentary"ISC is the federal government's open invitation to Canadian innovators: bring your best technology, and the country's top labs will put it to the test. Zentek answered that call with ZenGUARD™ Enhanced Air Filters. The NRC set a high bar - reduce airborne viral load, work with existing HVAC systems, no airflow penalty, and no harmful particulates - and our technology met every objective. Our addition to the PTC source list is the culmination of a multi-year journey with our partners at ISC and the NRC, and I want to thank everyone involved for their commitment and hard work. ZenGUARD™ Enhanced Air Filters are now available to every federal department in Canada with the NRC's validation behind it, and we look forward to delivering safer indoor spaces, lower energy use, and less waste across the federal service and beyond."About ZenGUARD™ Enhanced Air FiltersZenGUARD™ Enhanced Air Filters use patented graphene technology to improve indoor air quality without increasing airflow resistance. The result: safer indoor spaces, lower HVAC energy use and emissions, longer service intervals that reduce total cost of ownership, and less waste to the landfill - aligned with the Greening Government Strategy's Scope 2 emissions and waste diversion targets. Independently validated by the NRC and documented in three peer-reviewed ASHRAE publications. Manufactured in Canada, ZenGUARD™ Enhanced Air Filters are the only graphene filter technology delivering all four outcomes in a single drop-in product.About Zentek Ltd.
Zentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. The Company's core platforms are Albany Graphite, ZenGUARD™, and Triera. Albany is the Company's principal critical minerals asset and is advancing toward a Preliminary Economic Assessment targeted for completion in Summer 2026.Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.References (public)1 Source: Innovation, Science and Economic Development Canada, "Helping Canadians breathe easy with Zentek." https://ised-isde.canada.ca/site/innovative-solutions-canada/en/our-stories/helping-canadians-breathe-easy-zentek2 Source: Government of Canada, Greening Government Strategy. https://www.canada.ca/en/treasury-board-secretariat/services/innovation/greening-government/strategy.htmlFor more information:Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: mjiwan2@zentek.com
W: www.zentek.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/297250 Original: Zentek's ZenGUARD(TM) Enhanced Air Filters Now Available for Direct Procurement by All Federal Departments and Agencies

Zentek Accepting Canadian Commercial Orders for ZenGUARD(TM) Enhanced Air Filters Following Health Canada Regulatory ClassificationMay 6, 2026 12:00 PM
NewsfileZenGUARD(TM) Enhanced Air Filters leverage patented graphene-enhanced media tested in accordance with ASHRAE Standard 52.2, engineered to enhance filtration without increased pressure drop, energy consumption and carbon emissionsGuelph, Ontario--(Newsfile Corp. - May 6, 2026) - Further to its press release dated February 17, 2026, Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") is pleased to announce that it has received a revised classification by Health Canada's Pesticides Regulatory Directorate ("PRD") that ZenGUARD™ Enhanced Air Filters are not subject to regulation under the Pest Control Products Act. The product is exempt under section 3(1)(a) of the Pest Control Products Regulations on the basis that it operates through a mechanical mode of action. The classification resolves the regulatory matter most recently disclosed in the Company's press release and Management's Discussion and Analysis dated February 17, 2026. The classification is conditional, and any change to the design, use instruction, or marketing of the product could result in a re-assessment by Health Canada. Based on the classification by Health Canada, Zentek is now accepting commercial orders for ZenGUARD™ Enhanced Air Filters in Canada and is seeking to advance additional commercialization pathways, including licensing and the sale of ZenGUARD™-enhanced filter media to participants in the heating, ventilation, and air conditioning ("HVAC") supply chain. ZenGUARD™ is the subject of an issued Canadian patent (granted 2022; term to 2041) covering its application to personal protective equipment and HVAC applications.A Differentiated Approach to Enhanced Indoor AirConventional approaches to enhanced indoor air typically rely on denser filter media or increased outdoor air exchange. Both impose a meaningful energy cost on the building: denser media increases pressure drop and fan power; greater outdoor air exchange increases heating, cooling, and dehumidification load. In commercial and institutional buildings, HVAC is among the largest single contributors to electrical consumption.According to publicly available federal data, commercial and institutional buildings account for approximately 13% of Canada's total secondary energy use, with HVAC and ventilation systems representing the largest share of energy consumption within those buildings.1,2,3,4 As building owners, federal and provincial procurement programs, and institutional portfolios face tightening energy and emissions targets, the practical question is no longer just how to generate more clean energy - it is how to do more with the energy already being used.ZenGUARD™ is engineered as a coating, not as a single filter product. Applied to filter media using the Company's proprietary graphene-based formulation and process, the coating is designed to add filtration performance to the substrate filter media without an incremental pressure drop penalty. The Company's value proposition is built on the principle that better building performance should not require more energy to achieve.Commercial PathwaysZentek is pursuing four parallel pathways to bring ZenGUARD™ Enhanced Air Filters to Canadian customers:Direct purchase orders. Zentek is accepting orders from commercial, institutional, healthcare and industrial customers for ZenGUARD™ Enhanced Air Filters.Federal procurement. The Company intends to submit final documentation under its Innovative Solutions Canada's Pathway to Commercialization. A successful application could support direct procurement as an exclusive supplier of this type of innovation directly to the Government of Canada.Licensing. Zentek is engaging with established participants in the HVAC filter supply chain on potential licensing arrangements for ZenGUARD™.Coated filter media. The Company is exploring the sale of ZenGUARD™-enhanced filter media to filter manufacturers as a separate commercial pathway."When I came in on December 1, the classification of ZenGUARD™ Enhanced Air Filters was the largest open regulatory question on the product's Canadian pathway. The team's work since then has been to give Health Canada a complete, science-based picture of how this product actually works," said Mohammed (Moe) Jiwan, Chief Executive Officer of Zentek. "With the classification now in hand, our focus turns to commercial execution. The data that matters to HVAC engineers and building operators is already in the record: independently validated under ASHRAE 52.2, MERV 9 filtration with pressure drop equivalent to uncoated filters at both standard and high airflow conditions. The same air, the same fan power, a better filtration outcome. Commercial and institutional buildings represent a real share of national energy use, and HVAC is the largest single load inside those buildings. We believe our product gives building operators a new tool to support indoor air quality goals without increasing energy consumption. We are accepting purchase orders, advancing the Pathway to Commercialization application, and pursuing licensing and coated-media opportunities with established participants in the HVAC supply chain."About Zentek Ltd.Zentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. The Company's core platforms are Albany Graphite, ZenGUARD™, and Triera. Albany is the Company's principal critical minerals asset and is advancing toward a Preliminary Economic Assessment targeted for completion in Summer 2026.Forward-Looking StatementsThis news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.References (public)¹ Natural Resources Canada (NRCan), Office of Energy Efficiency, "Energy Use in Canada: Trends Publications - Total sectors (2020)" (sector shares of Canada's secondary energy use): https://oee.nrcan.gc.ca/publications/statistics/trends/2020/totalsectors.cfm
² Natural Resources Canada (NRCan), Office of Energy Efficiency, "Energy Use in the Commercial/Institutional Sector (2018)" (distribution of commercial/institutional energy use by end use; space heating is the largest share): https://oee.nrcan.gc.ca/publications/statistics/trends/2018/commercial.cfm
³ Natural Resources Canada (NRCan), Office of Energy Efficiency, Energy Efficiency Trends in Canada 1990 to 2013 (commercial/institutional sector secondary energy use shares, 2013): https://natural-resources.canada.ca/maps-tools-publications/publications/energy-efficiency-trends-canada-1990-2013
4 Natural Resources Canada (NRCan), Office of Energy Efficiency, Improving Energy Performance in Canada - Report to Parliament Under the Energy Efficiency Act (2006-2007), Chapter 1 (commercial/institutional sector share of secondary energy use, 2005): https://oee.nrcan.gc.ca/publications/statistics/parliament06-07/chapter1.cfmFor more information:
Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: mjiwan2@zentek.com
W: www.zentek.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/296231 Original: Zentek Accepting Canadian Commercial Orders for ZenGUARD(TM) Enhanced Air Filters Following Health Canada Regulatory Classification

Canadian Investment Regulatory Organization Trade Resumption - ZENMay 6, 2026 12:13 PM
PR Newswire (Canada) VANCOUVER, BC, May 6, 2026 /CNW/ - Trading resumes in:Company: Zentek Ltd.TSX-Venture Symbol: ZEN All Issues: YesResumption (ET): 12:30 PMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions Original: Canadian Investment Regulatory Organization Trade Resumption - ZEN

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - ZENMay 6, 2026 12:18 PM
PR Newswire (Canada) VANCOUVER, BC, le 6 mai 2026 /CNW/ - Reprise des négociations pour :Société : Zentek Ltd.Symbole à la Bourse de croissance TSX : ZENLes titres : OuiReprise (HE) : 12 h 30L'OCRI peut prendre la décision de suspendre (ou d'arrêter) temporairement les opérations à l'égard d'un titre d'une société cotée en bourse. Les arrêts des opérations sont mis en oeuvre afin d'assurer le bon fonctionnement d'un marché équitable. L'OCRI est l'organisme d'autoréglementation national qui surveille l'ensemble des courtiers en placement et l'ensemble des opérations effectuées sur les marchés des titres de capitaux propres et les marchés des titres de créance au Canada.SOURCE L’Organisme canadien de règlementation des investissements (OCRI) - Arrêts/Reprises Original: L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - ZEN

Canadian Investment Regulatory Organization Trading Halt - ZENMay 6, 2026 11:58 AM
PR Newswire (Canada) VANCOUVER, BC, May 6, 2026 /CNW/ - The following issues have been halted by CIROCompany: Zentek Ltd.TSX-Venture Symbol: ZENAll Issues: YesReason: Pending NewsHalt Time (ET): 11:51 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions Original: Canadian Investment Regulatory Organization Trading Halt - ZEN

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - ZENMay 6, 2026 12:00 PM
PR Newswire (Canada) VANCOUVER, BC, le 6 mai 2026 /CNW/ - L'OCRI a suspendu la négociation des titres suivants :Société : Zentek Ltd.Symbole à la Bourse de croissance TSX : ZENLes titres : OuiMotif : Nouvelle en attenteHeure de la suspension (HE) : 11 h 51L'OCRI peut prendre la décision de suspendre (ou d'arrêter) temporairement les opérations à l'égard d'un titre d'une société cotée en bourse. Les arrêts des opérations sont mis en oeuvre afin d'assurer le bon fonctionnement d'un marché équitable. L'OCRI est l'organisme d'autoréglementation national qui surveille l'ensemble des courtiers en placement et l'ensemble des opérations effectuées sur les marchés des titres de capitaux propres et les marchés des titres de créance au Canada.SOURCE L’Organisme canadien de règlementation des investissements (OCRI) - Arrêts/Reprises Original: Suspension de la négociation par l'Organisme canadien de réglementation des investissements - ZEN

Albany Graphite Launches Year Two Environmental and Social Baseline Program with ERM and Constance Lake First NationApril 28, 2026 7:33 AM
NewsfileProgram builds on prior site data and extends Zentek's active partnership with Constance Lake First Nation as Albany advances toward the Preliminary Economic Assessment targeted for completion in Summer 2026Guelph, Ontario--(Newsfile Corp. - April 28, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") today announced that its wholly-owned subsidiary Albany Graphite Corp. ("AGC") has engaged ERM Consultants Canada Ltd. ("ERM") to execute the 2026 environmental and social baseline program at the Albany Graphite Project (the "Project"). Constance Lake First Nation ("CLFN") members will be integrated into every field campaign planned for the season. The program builds on baseline work initiated in 2019 with the same consultant and advances Albany toward the standard that nuclear, defence, and allied-nation critical mineral buyers are increasingly setting for graphite origin and traceability.HighlightsYear Two, not Year One. Same consultant, building on the 2019 baseline and the prepared second-year work plan.Twelve baseline disciplines scoped for 2026. Covering water, air, wildlife, vegetation, archaeology, land use, socio-economic, and Indigenous knowledge, aligned to permitting and the 2026 field season.CLFN integrated into every field campaign. Members will participate across the 2026 baseline program, with findings shared with the community throughout.Built to the standard governments are setting. Canadian and allied-nation policy increasingly links procurement and funding to environmental rigour and meaningful Indigenous partnership.Parallel to the Preliminary Economic Assessment ("PEA"). Environmental and social workstreams are advancing alongside the technical and commercial workstreams feeding the PEA, targeted for Summer 2026.Why This MattersEnvironmental and social baseline studies are a regulatory prerequisite for federal and provincial mine permitting in Canada, particularly for critical mineral projects like Albany. These studies establish a multi-year picture of pre-development conditions – covering areas such as water, air, wildlife, vegetation, archaeology, land use, socio-economic factors, and Indigenous knowledge – that regulators, Indigenous partners, and future operators use to assess and responsibly advance a project.AGC is not starting from scratch. ERM completed the initial baseline studies at Albany in 2019 and supported Zentek's engagement with CLFN at that time, providing continuity in site knowledge and engagement. The program will build on that foundation through a 2026 Execution Plan tied to Albany's development path, permitting requirements, critical field windows, and risk reduction. The Execution Plan will define approximately twelve baseline programs by discipline and sequence field activities for the 2026 season, alongside the technical and commercial workstreams feeding the PEA targeted for Summer 2026.A Convergence of RequirementsThe market for certified, domestic, traceable, ultra-high-purity graphite is being shaped by two converging forces. First, Western governments and allied-nation buyers are mobilizing around supply-chain security agendas, including the U.S. Inflation Reduction Act and Foreign Entity of Concern provisions, Canada's Critical Minerals Strategy, U.S. Department of Energy funding initiatives, AUKUS Pillar 2 advanced capabilities programs, and NATO ally-shoring initiatives. Collectively, these frameworks are making non-Chinese origin an increasingly firm procurement condition across nuclear, defence, and advanced battery applications.1,2,3,4,5 Second, this is a broader set of expectations for how critical mineral projects must be advanced: with environmental rigour, meaningful Indigenous partnership, and transparent social licence. These expectations are increasingly embedded in Canadian policy frameworks, allied-nation procurement standards, and the capital-allocation criteria of institutional investors. Albany is being advanced at the intersection of both.Albany's chlorine-free electrothermal fluidized bed reactor process has demonstrated 5N+ nuclear-grade graphite (99.9992 wt.% Cg) from actual Albany feedstock at bench scale in collaboration with American Energy Technologies Company, as previously disclosed by the Company on September 22, 2025. This result is uncommon among graphite projects at this stage and positions Albany as potentially relevant to next-generation reactor technologies, including high-temperature gas-cooled reactors (HTGRs), molten salt reactors (MSRs), and tri-structural isotropic (TRISO)-fuelled small modular reactor platforms, as well as to defence and advanced manufacturing supply chains receiving active government funding in Canada and the United States.6,7Constance Lake First Nation PartnershipCLFN representatives are expected to be present during baseline field activities planned for the 2026 season, which may include water quality sampling, wildlife surveys, vegetation assessments, archaeological fieldwork, and socio-economic studies. Findings will be shared with the community as they are generated, not only through end-of-season reporting. Zentek believes this is the operating standard a modern critical mineral project should meet and reflects a relationship with CLFN that is active, ongoing, and central to how Albany is being advanced.Commentary"Our relationship with Constance Lake First Nation is not a line item in the development plan. It is foundational to how Albany is being built," said Mohammed (Moe) Jiwan, CEO of Zentek. "The 2026 program is Year Two, not Year One, and is being executed with the same consultant who completed the 2019 baseline work. That continuity matters – for the community, for the science, and for buyers of 5N+ nuclear-grade graphite who increasingly need to audit where their material comes from. Albany is being positioned to meet that standard as the PEA advances toward completion in Summer 2026."Mr. Peter Wood, P.Eng., P.Geo., Vice President, Development of AGC, a "Qualified Person" under National Instrument 43-101, has reviewed and approved the technical information contained in this news release.About Albany GraphiteThe Albany Graphite Project is an igneous-hosted graphite deposit located in Northern Ontario, held through the Company's wholly-owned subsidiary Albany Graphite Corp. Independent bench-scale testing conducted in collaboration with American Energy Technologies Company, as previously disclosed by the Company on September 22, 2025, confirmed ultra-high purity of 99.9992% with an equivalent boron concentration of 2.60 ppm, meeting published benchmarks for potential nuclear-grade applications, and demonstrated near-theoretical electrochemical performance for lithium-ion battery anodes. The Project is being advanced as a potential domestic North American source of critical-grade graphite for nuclear, battery, and defence supply chains. Graphite is designated a critical mineral by both the Government of Canada and the United States Department of Energy.About ZentekZentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. The Company's core platforms are Albany Graphite, ZenGUARD™, and Triera. Albany is the Company's principal critical minerals asset and is advancing toward a Preliminary Economic Assessment targeted for completion in Summer 2026.About ERMERM is the world's largest pure-play sustainability consultancy, with more than five decades of experience and a global team operating across more than 40 countries. ERM advises leading organizations on environmental, social, health, safety, risk, and sustainability matters, with deep experience supporting mining and critical minerals projects through baseline studies, Indigenous and stakeholder engagement, regulatory permitting, and sustainability strategy. ERM has supported Zentek on the Albany Graphite Project since 2015.Forward-Looking StatementsThis news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.References (public)1 U.S. Geological Survey (USGS). "2022 Final List of Critical Minerals" (Federal Register notice; Feb. 24, 2022). https://www.federalregister.gov/documents/2022/02/24/2022-04027/2022-final-list-of-critical-minerals
2 Natural Resources Canada. "Government of Canada Releases Updated Critical Minerals List" (News release; June 10, 2024). https://www.canada.ca/en/natural-resources-canada/news/2024/06/government-of-canada-releases-updated-critical-minerals-list.html
3 Natural Resources Canada. "The Canadian Critical Minerals Strategy" (2022). https://www.canada.ca/en/campaign/critical-minerals-in-canada/canadian-critical-minerals-strategy.html
4 U.S. Department of the Treasury / Internal Revenue Service. "Clean Vehicle Credits Under Sections 25E and 30D; Transfer of Credits; Critical Minerals and Battery Components; Foreign Entities of Concern" (Final regulations; May 6, 2024; T.D. 9995). https://www.federalregister.gov/documents/2024/05/06/2024-09094/clean-vehicle-credits-under-sections-25e-and-30d-transfer-of-credits-critical-minerals-and-battery
5 U.S. Department of Energy. "Foreign Entity of Concern (FEOC) Interpretive Guidance" (May 2024). https://www.energy.gov/cmei/manufacturing/foreign-entity-concern-interpretive-guidance
6 Canada Energy Regulator. "Market Snapshot: Canada's role in small modular reactor (SMR) technology" (Aug. 20, 2025). https://www.cer-rec.gc.ca/en/data-analysis/energy-markets/market-snapshots/2025/market-snapshot-canadas-role-in-small-modular-reactor-smr-technology.html
7 U.S. Nuclear Regulatory Commission (NRC). "Advanced Reactor Highlights." https://www.nrc.gov/reactors/new-reactors/advanced/highlights/index.htmlFor more information:
Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: mjiwan2@zentek.com
W: www.zentek.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/294395
Original: Albany Graphite Launches Year Two Environmental and Social Baseline Program with ERM and Constance Lake First Nation

Albany Graphite Corp. Engages Micon International to Complete New PEA for Albany Graphite ProjectApril 9, 2026 9:20 AM
NewsfileNew PEA to evaluate demonstrated high-purity thermal purification pathway and assess Albany's role in emerging North American critical mineral supply chains for nuclear energy, defence, and energy security applicationsGuelph, Ontario--(Newsfile Corp. - April 9, 2026) -  Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") is pleased to announce that its wholly-owned subsidiary Albany Graphite Corp. has engaged Micon International Limited ("Micon") to complete a new Preliminary Economic Assessment ("PEA") National Instrument 43-101 technical report for the Albany Graphite Project (the "Project"), located near Hearst, Ontario. Zentek expects the new PEA to be completed this summer.High-Purity PathwayA key differentiator that Micon will evaluate as part of its updated development case is Albany Graphite's tested bench-scale capability to produce 5N+ graphite (99.9992 wt.% Cg) directly from flotation concentrate (86% Cg) using an electrothermal fluidized bed reactor, without the use of chlorine. These results are intended to inform key process assumptions and product positioning to be assessed in the new PEA.PEA ScopeMicon will prepare the new PEA as a scoping-level study supported by an updated Mineral Resource Estimate. The study will evaluate a development case that considers the thermal purification process and current market conditions.Micon's work program will include:Updated Mineral Resource Estimate with revised cut-off grade analysis and current market pricingConceptual mining method evaluation, pit design optimization, and high-level production schedulingProcess flowsheet development and preliminary mass-balance assumptions, including evaluation of the thermal purification routeCapital and operating cost estimates at PEA-level accuracy, supported by budgetary equipment quotes, infrastructure, logistics, and site-support conceptsTailings, water management, and environmental and social considerations at scoping levelEconomic and sensitivity analysis, and preparation of the NI 43-101 technical report for public disclosureMineral Resource EstimateThe most recently filed Mineral Resource Estimate for the Project (effective April 30, 2023) reports, using cut-off grades of 1.22% graphitic carbon (Cg) for open pit Mineral Resources and 1.76% Cg for underground Mineral Resources, Indicated Mineral Resources of 22.9 million tonnes grading 4.07% Cg and Inferred Mineral Resources of 13.1 million tonnes grading 2.87% Cg. As part of its work program, Micon will prepare an updated Mineral Resource Estimate evaluating revised cut-off grade parameters and current market pricing.Next StepsFollowing completion of the PEA, Zentek expects to use the results to define priority next steps for Albany, which may include:Advancing additional metallurgical work and product qualificationEvaluating pilot-scale processing optionsRefining project execution and infrastructure conceptsConsidering the appropriate pathway for further engineering studiesCommentary"This PEA is a key milestone as we work to rerate the value of Albany based on its demonstrated potential in high-purity applications," said Mohammed (Moe) Jiwan, CEO of Zentek. "We have already proven at bench scale that Albany graphite achieves 5N+ purity using an electrothermal fluidized bed reactor, and we expect the PEA to translate that technical foundation into a current, NI 43-101-compliant economic framework. At the same time, North American and allied-nation demand for secure sources of ultra-high-purity graphite is accelerating as governments invest in energy security infrastructure, expand nuclear baseload capacity including small modular reactors (SMRs) to support AI and data centre growth, and work to rebuild critical mineral supply chains independent of foreign sources. With graphite designated a critical mineral by both Canada and the United States, and NATO allies prioritizing secure supply of strategic materials, we believe Albany is uniquely positioned to serve those markets."Mr. Peter Wood, P.Eng., P.Geo., Vice President, Development of AGC, a "Qualified Person" under National Instrument 43-101, has approved the technical information contained in this news release.About Albany GraphiteThe Albany Graphite Project is an igneous-hosted graphite deposit located in Northern Ontario, held through the Company's wholly-owned subsidiary Albany Graphite Corp. Independent bench-scale testing conducted in collaboration with American Energy Technologies Company as previously disclosed by the Company on September 22, 2025, has confirmed that Albany graphite achieves ultra-high purity of 99.9992% with an equivalent boron concentration of 2.60 ppm, meeting benchmarks for potential nuclear-grade applications, and has demonstrated near-theoretical electrochemical performance for lithium-ion battery anodes. The project is being advanced as a potential domestic North American source of critical-grade graphite for nuclear, battery, and defence supply chains. Graphite is designated a critical mineral by both the Government of Canada and the United States Department of Energy.About ZentekZentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. The Company's core platforms are Albany Graphite, ZenGUARD™, and Triera.Forward-Looking StatementsThis news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.For more information:Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: mjiwan2@zentek.com
W: www.zentek.comTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/290280
Original: Albany Graphite Corp. Engages Micon International to Complete New PEA for Albany Graphite Project

Zentek Ltd. Receives Favorable Judgment in Long-Standing LitigationMarch 13, 2026 8:30 AM
ACCESS NewswireOntario Superior Court Dismisses Claims Originally Exceeding $6 Million Against ZentekGUELPH, ON / ACCESS Newswire / March 13, 2026 / Zentek Ltd. (TSXV:ZEN)(NASDAQ:ZTEK) ("Zentek" or the "Company") announces that the Ontario Superior Court of Justice (Commercial List) has issued its Reasons for Judgment dated March 12, 2026, in the companion actions Eveleigh et al. v. Zenyatta; Zentek v. Eveleigh et al., 2026 ONSC 1510.BackgroundThe litigation arose following the removal of Aubrey Eveleigh, the Company's founder and former President and Chief Executive Officer, by shareholders at a special meeting held on May 11, 2018. The two companion actions were tried together before Justice Osborne of the Ontario Superior Court of Justice.OutcomeThe Court dismissed substantially all claims advanced by Mr. Eveleigh and his consulting firm, Eveleigh Geological Consulting Inc. Original claims, as filed, exceeded $6 million. At trial, the claims were refined and the Court denied all remaining monetary claims, specifically:A Success Fee claim of $282,500 - denied on the basis that the pre-feasibility study required to trigger the payment obligation was never commenced;Severance claims totaling $1,350,000 under the President's Agreement and related Memorandum of Agreement - found to be void and unenforceable as a result of breaches of fiduciary duty;Unpaid wages of $51,748.82 - denied;Defamation damages of $75,000 - denied, with the Court finding the relevant statements were factually accurate; andIndemnification claims of approximately $194,000 in costs and disbursements - denied.With respect to Zentek's claim for cancellation of 4.5 million founder shares and disgorgement of profits, the Court found that the shares had been properly issued and that there was no basis to set aside the issuance.CEO Comment"This judgment closes a chapter that has been part of Zentek's history since before I arrived on December 1," said Moe Jiwan, CEO of Zentek. "The Court's decision speaks for itself. What matters now is execution - on Albany, on ZenGUARD™, on Triera, and on building the foundation this company deserves. We move forward."About ZentekZentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. The Company's core platforms are Albany Graphite, ZenGUARD™, and Triera.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of applicable Canadian securities legislation and the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions and estimates that management considers reasonable at the time they are made, but which may prove to be incorrect. Readers are cautioned not to place undue reliance on forward-looking statements. Zentek undertakes no obligation to update forward-looking statements except as required by applicable law. Additional information about Zentek and its business activities is available on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov.For further information:
Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: mjiwan2@zentek.com
W: www.zentek.comSOURCE: Zentek Ltd.View the original press release on ACCESS NewswireOriginal: Zentek Ltd. Receives Favorable Judgment in Long-Standing Litigation

Zentek Provides PDAC 2026 Update - Government and First Nations EngagementMarch 9, 2026 4:10 PM
ACCESS NewswireCompany advances Albany Graphite relationships across federal, provincial, and community levelsGUELPH, ON / ACCESS Newswire / March 9, 2026 / Zentek Ltd. (TSXV:ZEN)(NASDAQ:ZTEK) ("Zentek" or the "Company") is pleased to provide shareholders with an update on its activities at and around the PDAC 2026 Convention held in Toronto from March 1-4, 2026.Government EngagementOn March 2, 2026, the Company participated in the TSX Canadian Mining Roundtable, hosted in conjunction with Greg Orencsak, Deputy Minister of Natural Resources Canada. The session brought together mining companies and senior government officials to discuss Canada's critical minerals strategy and the role of domestic projects in securing NATO-aligned supply chains. Albany Graphite's demonstrated nuclear-grade purity and Northern Ontario location were central to the Company's contributions to the discussion.The Company also held separate meetings with representatives of the federal government and Invest Ontario during PDAC week, continuing to advance Albany's positioning within federal and provincial critical minerals funding frameworks. These conversations are consistent with the government engagement strategy the Company outlined in its February 26, 2026, news release.First Nations EngagementThe Company attended a working session hosted by the Chiefs of Ontario covering Indigenous consultation frameworks applicable to mineral development in Ontario, including the Mushkegowuk Council Consultation Protocol and the Wabun Model for industry-community engagement throughout the mining sequence.Following this session, the Company held a working session with representatives of Constance Lake First Nation ("CLFN"), the Company's Indigenous partner at the Albany Graphite Project. Zentek and CLFN have an existing implementation agreement that sets out governance, roles, responsibilities, and a framework for a future project partnership structure. The working session was focused on advancing collaboration as the Company moves toward the initiation of environmental baseline studies and the preparation of a new Preliminary Economic Assessment, consistent with the Company's previously disclosed development roadmap.Mr. Peter Wood, P.Eng., P.Geo., Vice President of Development of the Company's wholly owned subsidiary Albany Graphite Corp., a "Qualified Person" under NI 43-101, has reviewed and approved the technical information contained in this news release.About Albany GraphiteThe Albany Graphite Project is an igneous-hosted graphite deposit located in Northern Ontario, held through the Company's wholly-owned subsidiary Albany Graphite Corp. Independent bench-scale testing conducted in collaboration with American Energy Technologies Company as previously disclosed by the Company on September 22, 2025, has confirmed that Albany graphite achieves ultra-high purity of 99.9992% with an equivalent boron concentration of 2.60 ppm, meeting benchmarks for potential nuclear-grade applications, and has demonstrated near-theoretical electrochemical performance for lithium-ion battery anodes. The project is being advanced as a potential North American source of critical-grade graphite for nuclear, battery, and defence supply chains.About ZentekZentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across clean air, next-generation materials, and critical minerals. The Company's core platforms are Albany Graphite, ZenGUARD™, and Triera.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of applicable Canadian and United States securities legislation. Forward-looking statements include, but are not limited to, statements regarding: the Company's plans to develop the Albany Graphite Project; potential government funding; alignment with NATO, federal, and provincial critical minerals mandates; collaboration with CLFN; and the Company's business strategy, plans, and objectives. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties that may cause actual results to differ materially. These risks include, but are not limited to, such risks set out in the Company's management discussion and analysis available on SEDAR+: The Company undertakes no obligation to update forward-looking statements except as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.For further information:
Mohammed (Moe) Jiwan
Chief Executive Officer, Zentek Ltd.
T: 416-709-8876
E: mjiwan2@zentek.com
W: www.zentek.comSOURCE: Zentek Ltd.View the original press release on ACCESS NewswireOriginal: Zentek Provides PDAC 2026 Update - Government and First Nations Engagement

Zentek Outlines Government Engagement Strategy and Announces Plans to Advance Albany Graphite Toward New Preliminary Economic AssessmentFebruary 26, 2026 5:00 PM
ACCESS NewswireAlbany Graphite uniquely positioned at intersection of NATO, federal, and provincial critical minerals mandates; Company accelerating path to Pre-Feasibility StudyGUELPH, ON / ACCESS Newswire / February 26, 2026 / Zentek Ltd. (TSXV:ZEN)(NASDAQ:ZTEK) ("Zentek" or the "Company") is pleased to provide shareholders with an update on its strategic government engagement and its accelerating path toward a Pre-Feasibility Study ("PFS") for the Albany Graphite Project.Government Engagement and Strategic PositioningAlbany Graphite is uniquely positioned at the intersection of multiple government priorities across federal, provincial, and allied-nation mandates. The Company is actively engaged with all levels of government to advance its project and secure non-dilutive funding.NATO and Allied Defence Supply ChainsIn December 2024, NATO released its first-ever list of 12 defence-critical raw materials, which includes graphite. NATO identified graphite as essential for the production of main battle tanks, naval vessels, and submarine components, noting that disruptions in graphite supply could impact the production of essential defence equipment.Canada's first Defence Industrial Strategy, launched by Prime Minister Carney on February 17, 2026, explicitly highlighted Canada's role as a reliable source of NATO defence-critical minerals, noting that Canada already produces 10 of the 12 minerals on NATO's list - including graphite. The strategy established a Defence Investment Agency to provide single-point coordination for defence-related mineral sourcing with fast-track approval processes.Zentek's Albany Graphite has demonstrated nuclear-grade material purity and physical properties (99.9992% purity, equivalent boron concentration of 2.60 ppm) through independent laboratory-scale testing conducted in collaboration with American Energy Technologies Company as previously disclosed by the Company on September 22, 2025, meeting key benchmarks for nuclear-grade graphite blocks including strength, density, electrical performance, and extremely low impurity levels. This positions Albany as a potential domestic source of defence-critical graphite for NATO allied supply chains.Federal Government ProgramsThe Company is actively engaged with multiple federal funding programs aligned with Canada's Critical Minerals Strategy:Strategic Resource Fund: Canada's $2-billion Critical Minerals Sovereign Fund provides equity investments, loan guarantees, and offtake agreements to advance strategic mining projects. Albany Graphite's nuclear-grade credentials and domestic supply chain positioning align directly with the Fund's mandate.Critical Minerals Research, Development and Demonstration Program ("CMRDD"): Extended to March 31, 2028, the CMRDD supports scale-up of transformative processing technologies - directly relevant to Zentek's proprietary fluidized bed reactor ("FBR") thermal purification process.Clean Technology Manufacturing Investment Tax Credit: Provides a refundable tax credit of up to 30% on eligible capital expenditures for critical mineral processing equipment, applicable to future FBR capital deployment.G7 Critical Minerals Production Alliance: Canada has unlocked 26 new investments and partnerships with nine allied countries to secure critical minerals supply chains. Graphite is among the eligible commodities, with several Canadian graphite projects already receiving support under this framework.Provincial Government - OntarioOntario's Critical Minerals Strategy (2022-2027) and the Ministry of Energy and Mines' 2025-2026 mandate provide a comprehensive framework that directly supports Albany Graphite's advancement:Critical Minerals Processing Fund: Ontario's landmark $500 million fund, announced in the 2025 provincial budget, supports processing facility development directly applicable to the Company's planned FBR processing operations.Critical Minerals Innovation Fund: An additional $25 million to accelerate commercialization and reduce reliance on foreign sources, supporting research, innovation, and industry partnerships.Invest Ontario: The Company continues discussions with Invest Ontario regarding potential project support. Ontario has positioned itself as the top jurisdiction in Canada for mineral exploration and development."One Project, One Process" (1P1P): Ontario's new permitting framework, launched in late 2025, is designed to cut approval times in half through a coordinated single-window approach - potentially accelerating Albany's path through the permitting process.Ontario's nuclear advantage is particularly relevant: with nuclear power supplying approximately 50% of the province's electricity and the construction of the first grid-scale Small Modular Reactor in the G7, Ontario is creating growing demand for nuclear-grade graphite that Albany is uniquely positioned to supply from within the province.United States - Defence and StockpilingIn 2025, the US Department of Defense announced its intent to procure up to $1 billion USD in stockpile materials, including graphite, with the Trump Administration announcing a $12 billion USD critical minerals stockpile initiative. As a near-border project with demonstrated nuclear-grade performance, Albany Graphite is positioned to potentially supply into US defence and energy supply chains.Accelerating Toward Pre-FeasibilityThe Company is taking concrete steps to de-risk the Albany Graphite Project and advance toward a Pre-Feasibility Study ("PFS") on the most reasonable timeline possible:New Preliminary Economic Assessment ("PEA")The Company intends to mandate an established engineering firm with prior knowledge of the Albany deposit to prepare a new PEA reflecting current market conditions, the Company's proprietary FBR purification technology, and the expanded market opportunity in nuclear-grade, battery-grade, and defence applications. A PEA was previously completed in 2015 and is not current under NI 43-101, having been prepared under a different market and technology paradigm. A new PEA is a Gate 1 requirement for multiple government funding programs and is expected to be a significant catalyst for the Company and its shareholders. The Company is targeting engagement in the current fiscal quarter.Second-Year Environmental Baseline WorkThe Company plans to initiate the second year of environmental baseline studies at the Albany site. This work is a prerequisite for the Environmental Assessment process and is required to advance toward a PFS and ultimately a construction decision. Early initiation of this workstream is intended to avoid unnecessary delays in the overall project timeline.Path to Pre-Feasibility StudyCollectively, these activities - the new PEA, environmental baseline work, FBR engineering advancement, and government funding engagement - are designed to systematically de-risk the Albany Graphite Project and position the Company to initiate a PFS in the most reasonable timeline possible.Management Commentary"Albany sits at the intersection of everything Western governments are prioritizing right now: NATO defence supply chains, nuclear energy, battery materials, and domestic critical minerals production. The breadth of government programs aligned with our project is unlike anything we've seen in the sector, and we intend to move through them systematically," said Mohammed (Moe) Jiwan, CEO of Zentek. "The updated PEA is a pivotal step. The previous study was completed in 2015 under entirely different market conditions and without our FBR purification technology. A new economic evaluation reflecting today's graphite market, expanded nuclear and defence applications, and our proprietary processing approach, is expected to provide an updated preliminary assessment of Albany's economic potential."Mr. Peter Wood, P.Eng., P.Geo., Vice President of Development of the Company's wholly owned subsidiary Albany Graphite Corp., a "Qualified Person" under NI 43-101, has reviewed and approved the technical information contained in this news release.About ZentekZentek Ltd. is a Canadian IP development and commercialization company focused on next-generation healthcare solutions and the development of the Albany Graphite deposit, a unique source of high-purity graphite located in Northern Ontario. Through its wholly owned subsidiary Albany Graphite Corp., its patented ZenGUARD™ technology platform, and its novel graphite purification process using fluidized bed reactor (FBR) technology, Zentek is building a portfolio of products and projects that serve the critical minerals, nuclear energy, EV battery, defence, and advanced materials sectors. Albany Graphite has independently demonstrated nuclear-grade performance (99.9992% purity) and near-theoretical anode performance in battery applications. For more information, visit www.zentek.com.Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of applicable Canadian and United States securities legislation. Forward-looking statements include, but are not limited to, statements regarding: the Company's plans to engage an engineering firm to prepare an updated PEA; plans to initiate second-year environmental baseline work; the advancement of FBR technology and engineering studies; the Company's intention to advance toward a PFS; anticipated government funding applications and their outcomes; alignment with NATO, federal, and provincial critical minerals mandates; and the Company's business strategy, plans, and objectives. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties that may cause actual results to differ materially. These risks include, but are not limited to: government funding programs may not approve the Company's applications; the updated PEA may produce results materially different from prior estimates; environmental studies may identify issues that delay or increase the cost of development; commodity prices and market conditions may change adversely; and the Company may not have sufficient capital to complete its planned activities. The Company undertakes no obligation to update forward-looking statements except as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.For further information:
Moe Jiwan, CEO
Zentek Ltd.
ir@zentek.com
www.zentek.comSOURCE: Zentek Ltd.View the original press release on ACCESS NewswireOriginal: Zentek Outlines Government Engagement Strategy and Announces Plans to Advance Albany Graphite Toward New Preliminary Economic Assessment

Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price RequirementFebruary 25, 2026 6:00 PM
ACCESS NewswireGUELPH, ON / ACCESS Newswire / February 25, 2026 / Zentek Ltd. ("Zentek"or the "Company") (TSXV:ZEN)(NASDAQ:ZTEK) announces that, further to its press release dated August 27, 2025, it has been granted a 180 calendar day extension from The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing on Nasdaq (the "Minimum Bid Price Requirement"), following the expiration of the initial 180 calendar day period to regain compliance on February 23, 2026. The Company now has until August 24, 2026, to meet the Minimum Bid Price Requirement set forth in Nasdaq Listing Rule 5550(a)(2).There is no immediate effect on the listing or trading of the Company's shares, which will continue to trade on the Nasdaq under the symbol "ZTEK." To regain compliance with the Rule, the Company must maintain a closing bid price of at least $1.00 per share for a minimum of ten (10) consecutive business days on or prior to August 24, 2026. Zentek's management intends to actively monitor the bid price for its Shares and will consider all available options to regain compliance with the Nasdaq minimum bid price requirement.About Zentek Ltd.Zentek Ltd. is a Canadian company advancing a portfolio of graphene-enabled advanced material technologies across healthcare, clean air and next-generation industrial applications. Zentek develops and scales materials-innovation solutions that aim to make partner products better, safer and more energy-efficient, while unlocking new high-value markets for ultra-high-purity graphite in nuclear, battery and semiconductor applications.For further information:Mohammed (Moe) Jiwan
Chief Executive Officer
Phone: 647-287-9582
Email: mjiwan2@zentek.comTo find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.Forward-Looking StatementsThis news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek refuses any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.SOURCE: Zentek Ltd.View the original press release on ACCESS NewswireOriginal: Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement

Zentek Provides Strategic and Regulatory UpdateFebruary 17, 2026 4:25 PM
ACCESS NewswireGUELPH, ON / ACCESS Newswire / February 17, 2026 / Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN) and (OTC:ZENYF), further to its letter to shareholders dated January 29, 2026, wishes to further outline its strategy, including the transformation of its operating model, near-term derisking steps for the Albany Graphite Project, and a disciplined approach to capital allocation intended to support sustainable value creation over time, as well as updates on its ongoing discourse with Health Canada.Strategic UpdateIn its shareholder letter, Zentek outlined its strategy on capital discipline, execution, and a focused approach to its core platforms: Albany Graphite, ZenGUARD™ and Triera - each governed by defined milestones, capital allocation criteria, and clear value creation roadmaps. The Company also described steps to reduce its cost base, pause or wind down non-core initiatives, and link future capital raises to specific, evidence-based milestones. Management believes these actions will, over time, support a more efficient operating structure and better reflect the risk adjusted value of the Company's core assets.Zentek believes this tight focus and clearer milestone-based disclosure provides a strong foundation for long term value creation. While no specific market outcome can be assured, management believes that continued derisking of Albany Graphite, progress on ZenGUARD™ under well-defined technical and commercial road maps, and sustained financing discipline should strengthen the Company's underlying fundamentals over time."Our goal is to create sustained, long-term value by continuing to derisk assets and develop credible cashflow opportunities," said Mohammed (Moe) Jiwan, Chief Executive Officer of Zentek Ltd. "By maintaining a strong focus on execution and capital discipline, we believe we are laying the groundwork for sustainable shareholder value creation."Derisking Albany GraphiteThe world is entering a decisive decade for critical minerals as governments and industry race to build secure, low-carbon supply chains for electric vehicles, grid-scale storage, advanced electronics and nuclear energy. Within this landscape, graphite stands out as an essential material whose supply is still heavily concentrated offshore, creating both risk and opportunity for projects that can deliver high-purity, North American-based production. For Zentek, Albany's ultra-high-purity, Ontario-hosted deposit is emerging as a strategically located asset with the potential to support cleaner, more resilient supply chains across nuclear, battery and other mission-critical applications.After several years in which capital markets, critical-minerals policy and geopolitics worked against new graphite developments, those headwinds are now shifting into tailwinds for projects like Albany. Growing government focus on secure, low-carbon supply chains, combined with accelerating demand in specialized high-purity segments such as small modular reactors, advanced battery anodes for EVs and data-centre backup, and ultra-high-purity components for semiconductors and other electronics, is materially improving the outlook for ultra-high-purity graphite in North America and reinforcing the strategic case for Albany.In this context, the latest independent laboratory testing confirming that Albany graphite can be purified to 5N (99.9992%) with an equivalent boron concentration of 2.60 ppm meeting the sub-3 ppm threshold required for nuclear applications, significantly reinforces the Company's conviction in Albany as an immediately relevant, strategically important opportunity. These results, achieved using a halogen-free purification process, validate Albany's potential to displace synthetic, emission-intensive, nuclear-grade graphite that has historically come predominantly from offshore producers. Additionally, they sharpen the urgency to move quickly while policy support, market interest and geopolitical momentum are aligned in the Company's favor. Albany Graphite remains Zentek's lead value creation asset and a central focus of the strategic reset.The Company's next near-term steps for Albany are designed to de-risk the project and position it to initiate a pre-feasibility study:Updating its Preliminary Economic Assessment
The Company is updating its Preliminary Economic Assessment to provide an up-to-date view of Albany's economic potential, using current cost, price and technical data so investors, governments and partners can clearly see the project's value and risks before major capital is committed.Expanding pilot-scale processing and generating samples representative of commercial production
By scaling up pilot-scale processing, the Company aims to prove that its flowsheet works reliably at larger scale and to produce graphite samples that closely mirror future commercial output, enabling qualification programs and discussions with potential offtake partners across nuclear, battery and other high-value markets.Advancing environmental and social baseline work with Constance Lake First Nation and local communities
Advancing environmental and social baseline studies, in partnership with the Constance Lake First Nation and nearby communities, will document existing conditions and local priorities so that project design, permitting and future impact assessments can be aligned with regulatory expectations and community interests from the outset.Ultimately, the Company's primary objective for the next 12 to 18 months is to progress Albany to a point where it can credibly support a spin-out, strategic partnership or other value-realization structure, creating flexibility to unlock value for shareholders if market conditions and project data support such a move.Development-on-Demand Innovation FocusZentek is, at its core, a materials-innovation company that develops and commercializes IP-rich coating technologies such as ZenGUARD™ to give partners differentiated performance in filtration, ice-phobic, fire-retardant, antimicrobial and other advanced surface applications.Building on this coatings platform, we are now adding ultra-high-purity carbon materials to our offering, including 5N (99.9992%) graphite with ultra-low boron content and chloride-free, nuclear-grade and anode-grade graphite for mission-critical markets. Albany fits naturally within this expanded model: once purified, its unique hydrothermal graphite is not a generic feedstock but a scarce, specification-ready material for nuclear-grade moderators, high-performance anodes and specialty high-temperature components.As Albany advances and we negotiate offtakes, joint ventures or other strategic structures, our intention is to bring more than a resource to the table by combining proprietary purification, application development and market access so that partners receive both advanced coatings and ultra-pure graphite tailored to their highest-value applications.Zentek is beginning to adopt a development-on-demand model, working with partners on targeted R&D programs that apply its materials IP, ZenGUARD™ production capabilities and analytics-enabled screening tools to specific performance, regulatory and cost challenges, with the goal of scaling this into a broader contract research and development offering over time. This development-on-demand approach is intended to generate additional value from the Company's IP portfolio today, while building capabilities, data and relationships that are expected to be directly relevant as Albany advances toward potential offtake, joint-venture or other strategic arrangements in nuclear-grade and other ultra-high-performance graphite markets."Zentek's strategy has the full support of the Board," said John Snisarenko, Chair of the Board of Directors. "We are focused on disciplined execution, converting our IP into recurring revenue, and advancing Albany in a way that maximizes long-term value for our shareholders."Health Canada UpdateAs previously reported by the Company on June 26, 2025, the Company announced that it had received a letter from Health Canada noting that it was considering the classification of ZenGUARD™ Enhanced Air Filters and inviting the Company to submit additional information regarding the appropriate regulatory classification. Over the course of the next several months, the Company has corresponded with Health Canada making submissions and providing scientific evidence and positions to properly classify ZenGUARD™ Enhanced Air Filters. Currently, Health Canada's position is that ZenGUARD™ Enhanced Air Filters are "pest control products" under the Pest Control Products Act and do not qualify as a medical device under the Food and Drugs Act.Zentek continues to correspond with Health Canada and submit additional information. Specifically, since December 1, 2025, the Company has been actively engaging with Health Canada's Pest Management Regulatory Agency to ensure they possess a complete, science-based understanding of ZenGUARD™ Enhanced Air Filters and their mode of action, including the most recent submission on February 5, 2026. As part of this engagement, the Company is providing detailed experimental protocols, third-party laboratory reports, and mechanical air flow reports, which support the Company's position that the primary mode of action of ZenGUARD™ Enhanced Air Filters is mechanical air flow disruption. The objective of this work is to ensure that classification and regulatory decisions are made on the basis of complete and transparent scientific evidence, and that any future data requirements or labelling conditions are clearly understood by all parties.Through this process, the Company is evaluating strategic options, including label claim modifications, as well as commercial feasibility in international markets. In the event Health Canada's determination is consistent with its current position, the Company expects that commercialization in Canada could require additional cost and time.Health Canada has been a constructive, science-driven partner throughout this process, engaging in open dialogue and giving the Company an opportunity to provide additional data to ensure ZenGUARD™ Enhanced Air Filters are evaluated on the basis of comprehensive, high-quality evidence. Zentek appreciates their collaborative approach and remains confident that this continued engagement will help define a clear, science-based regulatory path that supports both innovation and public health in Canada.About Zentek Ltd.Zentek Ltd. is a Canadian company advancing a portfolio of graphene-enabled advanced material technologies across healthcare, clean air and next-generation industrial applications. Zentek develops and scales materials-innovation solutions that aim to make partner products better, safer and more energy-efficient, while unlocking new high-value markets for ultra-high-purity graphite in nuclear, battery and semiconductor applications.For further information:Mohammed (Moe) Jiwan
Chief Executive Officer
Phone: 647-287-9582
Email: mjiwan2@zentek.comTo find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.Forward-Looking StatementsThis news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Such risks and uncertainties include, but are not limited to, operational risks in exploration development and production; delays or changes in plans with respect to exploration or development projects or capital expenditures; the uncertainties involved in the discovery and delineation of mineral deposits, resources or reserves; the uncertainty of resource and reserve estimates and the ability to economically exploit resources and reserves; the uncertainty of estimates and projections in relation to production, costs and expenses; the uncertainty surrounding the ability of the Company to obtain all permits, consents or authorizations required for its operations and activities; and health and safety and environmental risks. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.SOURCE: Zentek Ltd.View the original press release on ACCESS NewswireOriginal: Zentek Provides Strategic and Regulatory Update

Zentek Provides Strategic and Regulatory UpdateFebruary 17, 2026 4:25 PM
ACCESS NewswireGUELPH, ON / ACCESS Newswire / February 17, 2026 / Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN) and (OTC:ZENYF), further to its letter to shareholders dated January 29, 2026, wishes to further outline its strategy, including the transformation of its operating model, near-term derisking steps for the Albany Graphite Project, and a disciplined approach to capital allocation intended to support sustainable value creation over time, as well as updates on its ongoing discourse with Health Canada.Strategic UpdateIn its shareholder letter, Zentek outlined its strategy on capital discipline, execution, and a focused approach to its core platforms: Albany Graphite, ZenGUARD™ and Triera - each governed by defined milestones, capital allocation criteria, and clear value creation roadmaps. The Company also described steps to reduce its cost base, pause or wind down non-core initiatives, and link future capital raises to specific, evidence-based milestones. Management believes these actions will, over time, support a more efficient operating structure and better reflect the risk adjusted value of the Company's core assets.Zentek believes this tight focus and clearer milestone-based disclosure provides a strong foundation for long term value creation. While no specific market outcome can be assured, management believes that continued derisking of Albany Graphite, progress on ZenGUARD™ under well-defined technical and commercial road maps, and sustained financing discipline should strengthen the Company's underlying fundamentals over time."Our goal is to create sustained, long-term value by continuing to derisk assets and develop credible cashflow opportunities," said Mohammed (Moe) Jiwan, Chief Executive Officer of Zentek Ltd. "By maintaining a strong focus on execution and capital discipline, we believe we are laying the groundwork for sustainable shareholder value creation."Derisking Albany GraphiteThe world is entering a decisive decade for critical minerals as governments and industry race to build secure, low-carbon supply chains for electric vehicles, grid-scale storage, advanced electronics and nuclear energy. Within this landscape, graphite stands out as an essential material whose supply is still heavily concentrated offshore, creating both risk and opportunity for projects that can deliver high-purity, North American-based production. For Zentek, Albany's ultra-high-purity, Ontario-hosted deposit is emerging as a strategically located asset with the potential to support cleaner, more resilient supply chains across nuclear, battery and other mission-critical applications.After several years in which capital markets, critical-minerals policy and geopolitics worked against new graphite developments, those headwinds are now shifting into tailwinds for projects like Albany. Growing government focus on secure, low-carbon supply chains, combined with accelerating demand in specialized high-purity segments such as small modular reactors, advanced battery anodes for EVs and data-centre backup, and ultra-high-purity components for semiconductors and other electronics, is materially improving the outlook for ultra-high-purity graphite in North America and reinforcing the strategic case for Albany.In this context, the latest independent laboratory testing confirming that Albany graphite can be purified to 5N (99.9992%) with an equivalent boron concentration of 2.60 ppm meeting the sub-3 ppm threshold required for nuclear applications, significantly reinforces the Company's conviction in Albany as an immediately relevant, strategically important opportunity. These results, achieved using a halogen-free purification process, validate Albany's potential to displace synthetic, emission-intensive, nuclear-grade graphite that has historically come predominantly from offshore producers. Additionally, they sharpen the urgency to move quickly while policy support, market interest and geopolitical momentum are aligned in the Company's favor. Albany Graphite remains Zentek's lead value creation asset and a central focus of the strategic reset.The Company's next near-term steps for Albany are designed to de-risk the project and position it to initiate a pre-feasibility study:Updating its Preliminary Economic Assessment
The Company is updating its Preliminary Economic Assessment to provide an up-to-date view of Albany's economic potential, using current cost, price and technical data so investors, governments and partners can clearly see the project's value and risks before major capital is committed.Expanding pilot-scale processing and generating samples representative of commercial production
By scaling up pilot-scale processing, the Company aims to prove that its flowsheet works reliably at larger scale and to produce graphite samples that closely mirror future commercial output, enabling qualification programs and discussions with potential offtake partners across nuclear, battery and other high-value markets.Advancing environmental and social baseline work with Constance Lake First Nation and local communities
Advancing environmental and social baseline studies, in partnership with the Constance Lake First Nation and nearby communities, will document existing conditions and local priorities so that project design, permitting and future impact assessments can be aligned with regulatory expectations and community interests from the outset.Ultimately, the Company's primary objective for the next 12 to 18 months is to progress Albany to a point where it can credibly support a spin-out, strategic partnership or other value-realization structure, creating flexibility to unlock value for shareholders if market conditions and project data support such a move.Development-on-Demand Innovation FocusZentek is, at its core, a materials-innovation company that develops and commercializes IP-rich coating technologies such as ZenGUARD™ to give partners differentiated performance in filtration, ice-phobic, fire-retardant, antimicrobial and other advanced surface applications.Building on this coatings platform, we are now adding ultra-high-purity carbon materials to our offering, including 5N (99.9992%) graphite with ultra-low boron content and chloride-free, nuclear-grade and anode-grade graphite for mission-critical markets. Albany fits naturally within this expanded model: once purified, its unique hydrothermal graphite is not a generic feedstock but a scarce, specification-ready material for nuclear-grade moderators, high-performance anodes and specialty high-temperature components.As Albany advances and we negotiate offtakes, joint ventures or other strategic structures, our intention is to bring more than a resource to the table by combining proprietary purification, application development and market access so that partners receive both advanced coatings and ultra-pure graphite tailored to their highest-value applications.Zentek is beginning to adopt a development-on-demand model, working with partners on targeted R&D programs that apply its materials IP, ZenGUARD™ production capabilities and analytics-enabled screening tools to specific performance, regulatory and cost challenges, with the goal of scaling this into a broader contract research and development offering over time. This development-on-demand approach is intended to generate additional value from the Company's IP portfolio today, while building capabilities, data and relationships that are expected to be directly relevant as Albany advances toward potential offtake, joint-venture or other strategic arrangements in nuclear-grade and other ultra-high-performance graphite markets."Zentek's strategy has the full support of the Board," said John Snisarenko, Chair of the Board of Directors. "We are focused on disciplined execution, converting our IP into recurring revenue, and advancing Albany in a way that maximizes long-term value for our shareholders."Health Canada UpdateAs previously reported by the Company on June 26, 2025, the Company announced that it had received a letter from Health Canada noting that it was considering the classification of ZenGUARD™ Enhanced Air Filters and inviting the Company to submit additional information regarding the appropriate regulatory classification. Over the course of the next several months, the Company has corresponded with Health Canada making submissions and providing scientific evidence and positions to properly classify ZenGUARD™ Enhanced Air Filters. Currently, Health Canada's position is that ZenGUARD™ Enhanced Air Filters are "pest control products" under the Pest Control Products Act and do not qualify as a medical device under the Food and Drugs Act.Zentek continues to correspond with Health Canada and submit additional information. Specifically, since December 1, 2025, the Company has been actively engaging with Health Canada's Pest Management Regulatory Agency to ensure they possess a complete, science-based understanding of ZenGUARD™ Enhanced Air Filters and their mode of action, including the most recent submission on February 5, 2026. As part of this engagement, the Company is providing detailed experimental protocols, third-party laboratory reports, and mechanical air flow reports, which support the Company's position that the primary mode of action of ZenGUARD™ Enhanced Air Filters is mechanical air flow disruption. The objective of this work is to ensure that classification and regulatory decisions are made on the basis of complete and transparent scientific evidence, and that any future data requirements or labelling conditions are clearly understood by all parties.Through this process, the Company is evaluating strategic options, including label claim modifications, as well as commercial feasibility in international markets. In the event Health Canada's determination is consistent with its current position, the Company expects that commercialization in Canada could require additional cost and time.Health Canada has been a constructive, science-driven partner throughout this process, engaging in open dialogue and giving the Company an opportunity to provide additional data to ensure ZenGUARD™ Enhanced Air Filters are evaluated on the basis of comprehensive, high-quality evidence. Zentek appreciates their collaborative approach and remains confident that this continued engagement will help define a clear, science-based regulatory path that supports both innovation and public health in Canada.About Zentek Ltd.Zentek Ltd. is a Canadian company advancing a portfolio of graphene-enabled advanced material technologies across healthcare, clean air and next-generation industrial applications. Zentek develops and scales materials-innovation solutions that aim to make partner products better, safer and more energy-efficient, while unlocking new high-value markets for ultra-high-purity graphite in nuclear, battery and semiconductor applications.For further information:Mohammed (Moe) Jiwan
Chief Executive Officer
Phone: 647-287-9582
Email: mjiwan2@zentek.comTo find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.Forward-Looking StatementsThis news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Such risks and uncertainties include, but are not limited to, operational risks in exploration development and production; delays or changes in plans with respect to exploration or development projects or capital expenditures; the uncertainties involved in the discovery and delineation of mineral deposits, resources or reserves; the uncertainty of resource and reserve estimates and the ability to economically exploit resources and reserves; the uncertainty of estimates and projections in relation to production, costs and expenses; the uncertainty surrounding the ability of the Company to obtain all permits, consents or authorizations required for its operations and activities; and health and safety and environmental risks. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.SOURCE: Zentek Ltd.View the original press release on ACCESS NewswireOriginal: Zentek Provides Strategic and Regulatory Update

Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth PlanJanuary 29, 2026 4:35 PM
NewsfileCompany details next steps, priorities, and how capital will be allocatedGuelph, Ontario--(Newsfile Corp. - January 29, 2026) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") today announced that it has issued a letter to shareholders outlining a strategic reset focused on capital discipline, sharper execution, and advancing a smaller number of core platforms with clear paths to value creation.In the letter, Moe Jiwan, Zentek's Chief Executive Officer, outlines the Company's decision to narrow its focus to three core platforms: Albany Graphite, ZenGUARD, and Triera. Each will be managed against defined milestones, capital allocation criteria, and a 24-month roadmap. Other non-core initiatives have been paused or are being wound down to preserve capital and management focus.The shareholder letter also details actions underway to reduce the Company's cost base and better align spending with near-term priorities. These actions include workforce and facility optimization, tighter controls on corporate spending, and a more disciplined approach to capital allocation. Future capital raises will be linked to specific milestones rather than open-ended development programs. As part of this reset, the Company announces the departure of its Chief Science Officer, Colin van der Kuur. The responsibilities of the Chief Science Officer role have been redistributed across the existing technical leadership team."This reset is about protecting and rebuilding shareholder value," said Moe Jiwan, Chief Executive Officer of Zentek Ltd. "We are confident we have the right technical expertise and operating team in place to execute against our priorities, advance our core platforms, and hold ourselves accountable to clear milestones and timelines."The letter also outlines how each of the three core platforms will be advanced, how the Company is aligning its research and development efforts to support those priorities, the Company's approach to future financing, and new standards for transparency and reporting, including clearer segment-level financial disclosure and milestone tracking. The full shareholder letter is available on Zentek.com and on SEDAR+, and has been distributed directly to shareholders where an email address is available. For further information, please contact:
Mohammed (Moe) Jiwan
647-287-9582
Mjiwan2@zentek.comAbout Zentek Ltd.
Zentek Ltd. is a Canadian intellectual property development and commercialization company advancing a portfolio of graphene-enabled and advanced material technologies across healthcare, clean air and next-generation materials.To find out more about Zentek Ltd., please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on ZEN's SEDAR profile at www.sedarplus.ca.Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/282110
Original: Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan

We pump dump now pump above VWAP again $1.04

Other recent strategic News:
April 17, 2025
Zentek Announces Sale of Corporate Court Office
Guelph, ON – April 17, 2025, Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), announces that, as part of a strategic review of its portfolio and assets to support long-term business goals, it has entered into an agreement of purchase and sale (the “APS”) dated April 15, 2025, for the sale of its property located at 24 Corporate Court, Guelph, ON N1G 5G5 (the “Property”) which houses Zentek’s corporate office and laboratory space.

Under the terms of the APS, the Buyer will pay the Company an aggregate purchase price of $2.5 million. The Company will lease back the Property from the Buyer until January 31, 2026, allowing for a transition period and uninterrupted operations. The Company does not anticipate any disruption to its day-to-day operations or staff as a result of the sale. Relocation planning beyond the leaseback period is currently underway and will be communicated at a later date.

Completion of the sale of the Property is expected to occur on or around May 15, 2025.

Wow! No active posts since 2022, 2023, 2024?? Latest news bulletin:
April 29, 2025

Zentek Announces Purchase Order from Dexterra Group Inc. for ZenGUARDTM Enhanced Air Filter.

Zentek and Triera Biosciences Ltd. Receive $1.1 Million Government of Canada Contract to Test Multivalent Aptamer Technology

Guelph, ON – November 6, 2024, Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. (“Triera”) has received a $1.1 million Government of Canada contract to test its multivalent aptamer technology for the rapid drug discovery of therapeutics or prophylactics of highly pathogenic avian influenza (“HPAI”) A(H5N1).

Highlights:

The Government of Canada has identified the life sciences sector as a priority of the Canadian economy and is seeking advanced medical technology solutions to address ongoing challenges
Triera was awarded a $1.1 million Government of Canada R&D contract through Innovation, Science and Economic Development Canada's (“ISED”) Innovative Solutions Canada (“ISC”) program: Health Advanced And Emerging Medical Technologies
Triera’s multivalent aptamer technology was selected for its potential to be used as a rapid drug development platform
Government of Canada testing partners include Health Emergency Readiness Canada (“HERC”) within ISED and Defence Research and Development Canada (“DRDC”), the science and technology organization of the Department of National Defence (“DND”)
The test will help develop a prophylactic and therapeutic for HPAI A(H5N1) following the multivalent aptamer strategy that successfully produced a SARS-CoV-2 aptamer
Triera has proven the capability of the multivalent aptamer platform by developing a universal therapeutic and prophylactic that is effective against all variants of SARS-CoV-2. The contract will allow Triera to prove the capability for developing a lead candidate for HPAI A(H5N1).

HERC is a new federal organization within ISED dedicated to protecting Canadians against future pandemics and delivering on Canada’s life sciences and medical countermeasures readiness objectives. HERC will provide a sustained focus on advancing life sciences industrial capabilities and innovation to respond to health threats, building on significant achievements in the sector since 2020, including $2.2B that has been invested under Canada’s Biomanufacturing and Life Sciences Strategy.

DRDC is Canada's defence science, technology, and innovation leader. DRDC develops and delivers new technical solutions and advice to the DND, the Canadian Armed Forces, and safety and security communities. This is accomplished by working with partners in industry, academia, other government departments and international allies.

The contract requires Triera to develop a lead candidate for HPAI A(H5N1) within six months of the project initiation. The lead candidate will be tested for its efficacy as a therapeutic and prophylactic along with its safety profile by the Miller Laboratory at McMaster University.

“We are very pleased that our multivalent aptamer platform has been recognized through this ISC Program Testing Stream. We are working with government organizations that understand the significance of our avian flu program and can promote and support further development of our technology. Upon successful completion, Triera will be eligible for further government investment and recognition from Canada and its key allies,” said Greg Fenton, CEO of the Company and Triera.

“The potential for an avian influenza pandemic continues to grow and the consequences of a new variant, which would allow human-to-human transmission, could lead to devastating results,” Triera’s advisor, Dr. Matthew Miller said, “As with national security, the need for an outbreak response must be regarded as a failure to prevent.”

About Triera Biosciences Ltd.

Triera holds an exclusive, worldwide royalty bearing license from McMaster University to use and practice all aptamer and DNAzyme uses developed through the collaboration with the Li Lab by McMaster University for the next 20 years. Triera and McMaster’s combined expertise and capabilities in aptamer technology offer significant potential to reduce the cost and time required for the development of new treatments.

Zentek Provides Regulatory Update for
ZenGUARD™ Enhanced Air Filters
Guelph, ON – October 31, 2024, Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company announces that it has withdrawn its submission to the Health Canada Pest Management Regulatory Agency (“PMRA”) for its ZenGUARD™ Enhanced Air Filters. Based on feedback received from PMRA, and continued analysis of the Canadian regulatory environment, the Company believes there are other, more cost-effective, and timely pathways, to bring ZenGUARD™ Enhanced Air Filters to market in Canada. The Company has been evaluating and planning for these potential alternative options in parallel with the PMRA assessment process over the last several months and will now shift its focus to these other pathways.

“Our top priority as a Company is ensuring we do everything we can to create value for our stakeholders as quickly and effectively as possible, which is why we are shifting our focus to pursue other pathways to market in Canada for ZenGUARD™ Enhanced Air Filters,” said Greg Fenton, CEO of Zentek.

“Importantly, we know that one of the biggest challenges facing society is climate change and building decarbonization. Buildings contribute nearly 40% of global energy-related CO2 emissions – and ZenGUARD™ Enhanced Air Filters are one of the only tools in the toolbox to help control infectious aerosols without significantly increasing energy consumption and emissions. The sooner we can bring ZenGUARD™ Enhanced Air Filters to market, the sooner we can do our part to help reduce emissions while keeping people safe indoors – not only in Canada, but globally as well.”

Zentek Provides Market Update on ZenGUARD™ Antimicrobial Surgical Masks


Guelph, ON – October 17, 2024, Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company, is pleased to provide an update on recent commercialization activities for its ZenGUARD™ Antimicrobial Surgical Masks.

As previously announced on July 24, 2024, the Company embarked on a Canada-wide sampling program for dental professionals facilitated by Henry Schein Inc. (“Henry Schein") that saw ZenGUARD™ Antimicrobial Surgical Masks included in product shipments to Henry Schein customers across Canada. As a result of this program and the unique value proposition ZenGUARD™ Antimicrobial Surgical Masks bring to dental practitioners and their patients, the Company is now seeing increased demand from Henry Schein. Henry Schein (Nasdaq: HSIC) is the world’s largest provider of health care solutions to office-based dental and medical practitioners with a presence in 33 countries.

Zentek continues to explore opportunities in other markets including in the beauty space and in international healthcare and dental markets where demand for surgical masks is expected to be more stable long term.
As previously announced on April 24, 2024, the Company applied to the Food and Drug Administration (FDA) for authorization to market and sell its ZenGUARD™ Surgical Masks in the United States. The FDA has requested additional information regarding ZenGUARD™ and the Company is currently evaluating the additional information requests.

“In addition to better protection against infectious agents, ZenGUARD™ Antimicrobial Surgical Masks are also proven to eliminate 99.9% of bacteria, which can collect on the skin when wearing a surgical mask for extended periods and cause acne. We believe this unique value proposition will continue to drive increased demand in the dental market and is a very natural fit for the beauty industry as well. We look forward to continuing to build on the recent success generated in the Henry Schein sampling program and to expanding the platform globally.” said Greg Fenton, Zentek CEO.

ZTEK new week Low

Zentek Announces Distribution and Supply Agreement with Henry Schein, Inc.

Guelph, ON

August 24, 2023

Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), a graphene technology development and commercialization company has signed a Distribution and Supply Agreement with Henry Schein, Inc. (Henry Schein). This initial agreement will be for a period of three years and is for Canada and the United States. Sales of ZenGUARD™ surgical masks in the United States will commence upon facility establishment registration and issuance of market clearance from the Food and Drug Administration.

Henry Schein is the world’s largest provider of health care solutions to office-based dental and medical practitioners. The Henry Schein team will market and distribute ZenGUARD™ surgical masks to dental practices in the U.S. and Canada.

Greg Fenton, CEO of Zentek commented: “Henry Schein has been a leading company in the sales and distribution of health care products for over 90 years and been recognized by FORTUNE® as one of the World’s Most Admired Companies. We are proud to have our ZenGUARD™ surgical masks carried by one of the most respected distributors in the world. We believe this is another meaningful step toward securing volumes in a market segment with stable demand for surgical masks. While our focus is currently on surgical masks in Canada, we look forward to exploring other opportunities for our ZenGUARD™ platform in the dental space with Henry Schein.”

About Zentek Ltd.

Zentek is an ISO 13485:2016 certified graphene technology company focused on the research, development and commercialization of graphene-based novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek's patented technology platform ZenGUARD™, is shown to have 99% antimicrobial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario. Zentek's patent pending ZenARMOR™ technology platform is focused on corrosion protection applications.

For further information:
Investorrelations@zentek.com

$ZTEK - Up 6.4% Pre-Market/ Current Price $1.56
Zentek and McMaster Announce Positive Results for Aptamer-Based Technology with Therapeutic Potential

https://finance.yahoo.com/news/zentek-receives-iso-13485-2016-111500895.html

More news
Zentek Files Patent Applications for ZenGUARD™ in Multiple New Jurisdictions

Guelph, ON

April 5, 2023

Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), a graphene technology development and commercialization company, has filed patent applications for ZenGUARD™ in 47 countries.

The examiner for the Patent Cooperation Treaty, the international patent law treaty, that reviewed the ZenGUARD™ patent application opined that it met all 3 requirements to be granted a patent: novelty, an inventive step and industrial applicability. The Company has also been granted a patent for ZenGUARD™ by the Canadian Intellectual Property Office, as previously announced on December 7th, 2022. Examiners in other jurisdictions will use these actions as a basis for their own examinations and granting of patents in their respective countries.

The patented ZenGUARD™ antimicrobial technology platform has demonstrated it is a powerful solution for deactivating pathogens and increasing bacterial and viral filtration efficiency of both surgical masks and HVAC filters.

Based on the above information, the Company has decided to file patents in 47 new jurisdictions, including the United States, Europe, India and others and expects to be successful in all of them. The patent covers the chemical formula for ZenGUARD™, a fabrication method along with its application to various substrates, including surgical mask material, other personal protective equipment (PPE) and heating, ventilation, and air conditioning (HVAC) filters.

“We expect our patented ZenGUARD™ antimicrobial platform can provide numerous opportunities to give our business partners a competitive advantage in their respective markets, which we believe will make it a cornerstone for Zentek,” commented Greg Fenton, CEO of Zentek. He continued, “Importantly, this demonstrates our ability to move from a concept in the lab to a patent-protected technology platform that we hope to commercialize in numerous ways with several partners – all with the aim of making their products better, safer, and greener. We expect to follow a similar path for our other nanotechnologies, including ZenARMOR™, our patent-pending corrosion technology, and others.”

Jai-Hinde! Love India & “Grandpa’s Kitchen!!”……” MIX-WELL!!” Team ZENTEK!!

Chico

Update



Zentek NEWS

Zentek Engages Arka BRENStech Pvt Ltd to Develop Opportunities in India

Guelph, ON

March 30, 2023

Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company, has signed an agreement (the “Agreement”) with Arka BRENStech Pvt Ltd (“BRENStech”), a company incorporated under the laws of the Republic of India (India), pursuant to which BRENStech will act as a local partner to Zentek as it seeks to develop business opportunities in India.

Zentek has been working with Mr. Gaurav Kumar, a director of BRENStech, over the last year to understand the Indian market. BRENStech’s primary focus under the terms of the Agreement will be to establish sales and distribution opportunities for Zentek masks and HVAC filters and potentially other Zentek products as they become available, however BRENStech will also provide services under the Agreement to connect Zentek with university research facilities, assist with the navigation of applicable regulatory regimes, and to source potential manufacturing partners for Zentek’s business opportunities in India and globally.

To date, BRENStech has performed market research of the Indian market for surgical masks where samples were trialed in hospitals and clinics and has reported positive feedback and Zentek has shipped 2.1 million masks to support initial sales efforts. The personal protective equipment (“PPE”) market in India is valued at $1 billion USD and India is currently the world’s second largest manufacturer of PPE according to the Economic Times, India.
“We see significant opportunities in India, both as a market for Zentek’s innovative products and as a potential manufacturing hub for Zentek going forward” said Greg Fenton, CEO of Zentek. “Having a strong partner in India with business, research and development, regulatory and political connections will be invaluable as we seek to grow our opportunities both in India and globally.”

Currently, India is the world’s 5th largest economy and expected to grow to the 3rd largest by 2030 according to the International Monetary Fund. India is projected to host over 1.5 billion people by 2030 making it the highest population in the world. Currently the estimated middle class has approximately 350 million people and targeted to reach 600 million by 2030. India offers significant opportunities for Zentek and its partners: Sales and distribution, strong manufacturing infrastructure along with world-class research and development.

About Zentek Ltd.
Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond.

Zentek’s patented ZenGUARD™ coating is shown to have 99% antimicrobial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC systems. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.

About Arka BRENStech Pvt Ltd.

BRENStech is a leading consulting company that is focused on technology and has a history of developing and deploying cutting-edge technologies. The company works primarily in the realm of environmental sustainability and renewable energy but is also well diversified and active in many other areas of industry and is well positioned for companies entering India under joint ventures.

BRENStech has been in business for over 10 years and has corporate offices in Gurugram (on the outskirts of New Delhi), Hyderabad, Bangalore, and Chandigarh which provide a presence throughout India. The company also has an extensive network established in the private and public sectors as it works with a wide range of SMEs as well as large multinationals. The company maintains a close working relationship with numerous departments and agencies throughout all levels of Government and participates actively in policy formation. BRENStech offers its partners a strong combination of technical expertise and business knowledge to help bring emerging technologies to market.


For further information:
Mitch Swergold
Tel: (917) 930-8723
Email: mswergold@zentek.com

To find out more about Zentek Ltd., please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on ZEN’s SEDAR profile at http://www.sedar.com/.

Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.




Zentek on Facebook!
Zentek on Twitter!
Zentek on Instagram!
Zentek's Website
Zentek on LinkedIn!
Copyright © 2023 Zentek Ltd., All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
Zentek Ltd.
210-1205 Amber Drive
Thunder Bay, ON P7B6M4
Canada

Add us to your address book


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp

How about this ?
Guelph, ON

March 22, 2023

Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company, announces that SGS Standard Technical Services Co. (“SGS”) recently conducted tests to determine the extent of the antimicrobial properties and the time required to achieve deactivation of bacteria and virus on ZenGUARD™-coated mask material.

“Our goal at Zentek from early on in the pandemic was to create a technology that could improve the health and safety of our valued frontline healthcare workers” said Greg Fenton, CEO of Zentek. “Our patented ZenGUARD™ antimicrobial technology with 99.99% bacterial and viral filtration efficiency brings an added level of protection that doctors, nurses and all frontline healthcare providers deserve. We are excited to bring our unique ZenGUARD™ surgical masks to them via our Canadian distribution partnership with Southmedic Inc.”

Key Data points

Antibacterial testing completed by SGS following AATCC 100-2019 Test
Method for Antibacterial Finishes on Textile Material
Antiviral testing completed by SGS and followed ISO 18184: 2019 Textiles – Determination of antiviral activity of textile products TCID50 method
The ZenGUARD™-coated mask fabric demonstrated over 99.99% antibacterial effectiveness after 1 hour where 260,000 Escherichia Coli (E. coli) Colony Forming Units (CFU) was reduced to under 100 CFU.
The untreated control mask samples saw 120,000 E. coli CFU grow to 2.5 million in 1 hour and 1.1 billion in 8 hours
The ZenGUARD™-coated mask fabric demonstrated 86.7% antiviral effectiveness after 1 hour against H1N1 and 99.7% after 8 hours
These meaningful reductions in bacterial and viral load may have an impact in the reduction of infectious disease in high-risk environments
Impact in High-Risk Environments
In the context of high-risk indoor settings, such as hospitals where doctors, nurses and other healthcare professionals and patients wear surgical masks and are exposed to dangerous bacteria and viruses daily, this data offers compelling evidence that ZenGUARD™-coated mask material can provide additional protection with the strong antimicrobial properties of ZenGUARD™. The reduction in bacterial and viral growth in the mask materials may contribute to protecting doctors, nurses, other hospital staff and patients, as well as long term care residents and their caretakers, from mask acne to potentially preventing significant disease from bacterial or viral infections.

Southmedic Inc. is Zentek's exclusive distribution partner in Canada for hospitals, clinics, long-term care, nursing homes and community health care services. For any purchase requirements, please contact Southmedic Customer Service at custserv@southmedic.com or by phone at 1-800-463-7146, Mon - Fri 8:30am - 5:00pm.

About Zentek
Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond.
Zentek’s patented ZenGUARD™ coating is shown to have 99% antimicrobial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC systems. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.

For further information:
Mitch Swergold
Tel: (917) 930-8723
Email: mswergold@zentek.com

To find out more about

Maybe this will help

https://finance.yahoo.com/news/zentek-announces-successful-phase-2-130000568.html

C'mon ZEN! Still under 3$... Need to sign a nice "DEAL$$$$" & this will grow wings!
I've been holding underwater.... here....
Knowing ZEN has the Goods. It's time to get back over 5$/share on volume Mr. Fenton!

Chico

Update

https://finance.yahoo.com/news/zenteks-zenguard-tm-patent-application-130000917.html

New update

https://finance.yahoo.com/news/zentek-provides-battery-technology-development-120000124.html

Zentek’s ZenGUARD™ Patent Application Allowed by the Canadian Patent Office

Guelph, ON

September 27, 2022

Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property (IP) development and commercialization company, is pleased to announce that on September 16, 2022, it’s Canadian patent application directed to its ZenGUARD™ technology, for use on personal protective equipment (“PPE”), and heating, ventilation, and air conditioning (“HVAC”), has been allowed by the Canadian Intellectual Property Office including all 54 claims made in the application. Zentek is now working with its IP counsel to map out the strategy to extend patent protection of its commercial rights in all global jurisdictions of interest.

“This is tremendous news for our company and shareholders,” said Greg Fenton, CEO for Zentek. “Our team has worked diligently with our patent attorneys to map out a strong strategy to protect ZenGUARD™ and our other graphene-based technologies. By moving this technology from the lab all the way through to a patent and commercialization, this milestone validates the Zentek business model of being an intellectual property development and commercialization company. In two short years we have taken this game changing technology for the fight against Covid-19 and other airborne pathogens from a concept to a fully protected asset of the company.”

September 20, 2022

Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company, announces that Greg Fenton, CEO, will hold investor meetings and present at this year’s Sidoti Small-Cap Virtual Investor Conference, which will be held September 21-22, 2022.
Mr. Fenton will deliver his corporate presentation on Thursday, September 22nd at 12:15PM ET, and can be accessed live here: https://sidoti.zoom.us/webinar/register/WN_JpxPXpukRwSFbGSx-di-BA
The Sidoti Small Cap Conference is a virtual event featuring dynamic, small-cap companies interacting with top institutional investors. Sidoti is a provider of independent securities research focused on small and micro-cap companies and the institutions that invest their securities. Their investor conferences have emerged as a leading forum for interaction between issuers and investors in the small and micro-cap investment community.
“The value proposition for Zentek is tremendous as our company continues to advance its IP pipeline and commercialization opportunities in a number of areas, most notably with ZenGUARD™ in the personal protective equipment and indoor air filtration markets,” said Greg Fenton, CEO. “We’re in good company at this year’s conference and look forward to reinforcing our unique value proposition with US investors.”

For more information, and to register, visit https://www.sidoti.com/events/fall-small-cap-virtual-conference.


About Zentek Ltd.
Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond.
Zentek’s proprietary ZenGUARD™ coating is patent-pending and shown to have 99% antimicrobial activity, including against COVID-19, for use in PPE and potentially HVAC systems and other industries. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.

For further information:
Tyler Dunn
Tel: (306)717-6745
Email: tdunn@zentek.com

Zentek Provides Update on Icephobic Coating Technology

Guelph, ON

September 19, 2022, Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company, has successfully completed sand erosion testing at the National Research Council (“NRC”) in Ottawa and rain erosion testing at the Anti-icing Materials International Laboratory (“AMIL”) in Quebec on Zentek’s patent-pending Icephobic Coatings. These results, when taken with the strong performance under accelerated ageing announced March 14, 2022, demonstrate that the company’s icephobic technology is durable in adverse conditions for both wind turbine and drone industries, where Zentek is currently maintaining its focus.
Summary of overall results to date as reported by the NRC and AMIL:

As reported in November 2021, icephobicity tests at the NRC yielded strong and consistent results with an average shear stress of 20 kPa required to passively remove ice accretion (results under 100 kPa are considered to demonstrate low adhesion). Retesting a year later yielded the same results, demonstrating strong stability.
Flight tests in real-world icing conditions demonstrated good performance of Zentek’s coating, with results indicating retardation of ice accretion (icephobicity) and low adhesion to accreted ice.
1,000 hours of UV exposure, equivalent to two years of UV damage in Canada, slightly increased the ice adhesion properties to 43 kPa, which is still considered to be an effective coating in removing ice.
Sand erosion testing demonstrated medium to good performance at a high speed of 540 km/h.
Rain erosion testing at AMIL demonstrated good performance at 160 km/h and 320 km/h based on our interpretation, speeds at which the leading edge of wind turbines blade tips are exposed.
NRC drone testing demonstrated consistent results of maintaining control of rotor thrust in icing conditions while uncoated blades failed to maintain thrust in the same indoor controlled environment.
NRC is preparing for outdoor, real-world environment testing of drone rotor blades with Zentek’s icephobic coating this winter.
AMIL is testing the performance of Zentek’s coating on a small wind turbine in an indoor controlled environment.

“We are very happy with both the performance and durability test results for our icephobic coating and look forward to continued testing and demonstration of our technology,” said Greg Fenton, CEO of Zentek. “Ice accretion is a significant problem in the drone and wind turbine industries with few robust solutions currently available. We believe our patent-pending technology may be a new innovative approach to addressing a significant global need and look forward to continued discussions with drone and wind turbine market participants who see value in potentially more effective icephobic technologies.”

Zentek has filed a full patent application with the Patent Cooperation Treaty, the international patent office, on August 2nd, 2022, for Nanomaterial-Enhanced Elastomer for Passive Ice Accretion Prevention. The patent application will publish approximately 6 months from the date of filing, marking the beginning of the 12-month national phase for Zentek to apply directly in each country of interest.

About Zentek Ltd.
Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond.
Zentek’s proprietary ZenGUARD™ coating is patent-pending and shown to have 99% antimicrobial activity, including against COVID-19, for use in PPE and potentially HVAC systems and other industries. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.

For further information:
Tyler Dunn
Tel: (306) 717-6745
Email: tdunn@zentek.com

To find out more about Zentek Ltd., please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on ZEN’s SEDAR profile at http://www.sedar.com/.

Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

September 15, 2022

Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq: ZTEK; TSX-V:ZEN an intellectual property development and commercialization company, reports, further to its press release dated April 11, 2022, that it has received the final report from Phase 1 testing under its Innovation Solutions Canada (“ISC”) Testing Stream contract, which notes that all Phase 1 targets were met including: (i) a sufficient reduction in live airborne test organisms without modification to existing HVAC systems, (ii) no reduction in air flow rates, and (iii) no significant shedding of the ZenGUARD™ coating. ZenGUARD™-coated HVAC filters demonstrated a maximum improvement of 99% compared to equivalent MERV-rated uncoated filters using a bacteriophage (a SARS-COV-2 surrogate).

“The significant increase in filtration efficiency of pathogen-laden water droplets, without an impact to airflow rates, creates a potentially powerful solution in the HVAC space,” said Greg Fenton, CEO of Zentek. “Working with current systems, and not requiring additional energy or changes to existing equipment, our technology could be a simple and energy-efficient approach to providing cleaner air for indoor spaces and is highly supportive of current global indoor air quality initiatives.”


Phase 1 testing was conducted by CremCo Laboratories with assistance by the Aerospace Research Centre, a department of the National Research Council of Canada. Zentek is now in Phase 2 Testing at the National Research Council to demonstrate a reduction in live airborne surrogate contamination within a modular classroom environment, simulating a real-world environment. The Company will report results when completed and validated.


About Zentek Ltd.

Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond.

Zentek’s proprietary ZenGUARD™ coating is patent-pending and shown to have 99% antimicrobial activity, including against COVID-19, for use in PPE and potentially HVAC systems and other industries. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.


For further information:
Tyler Dunn?
Tel: (306) 717-6745?
Email: tdunn@zentek.com

Zentek CEO Greg Fenton talks about bringing new antimicrobial HVAC filters to market


HVAC COULD = $$$$ CONTRACTS
https://www.zentek.com/
https://www.zentek.com/files/2022_Zentek-Corporate-Presentation_June-10-2022.pdf
Added a few shares here...

Chico

wow 14.99 this morn>??? what~!

Float
99,118,058
03/01/2022

$ZTEK: Approval to uplist on NASDAQ made on March 7 !!!!!!!!



And here we are today



https://twitter.com/zentekltd/status/1500818487245217793?s=20







GO $ZTEK

$ZTEK: Opening up to 8.37 !!!!!!!!!!!



Biggggggggggggg move higher in PreMarket.........




Zentek Ltd., formerly ZEN Graphene Solutions Ltd., is a Canada-based intellectual property development and commercialization company. The Company is focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. The Company's technology helps filter and deactivate pathogens to reduce the risk of transmission. The Company is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The Company is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. It also intends to focus on commercializing few layers graphene and developing technology to produce monolayer graphene. The Company's manufacturing facility is located at 1123 York Rd, Guelph, Ontario.




$TMNA is next to do the same thing as it uplists from OTC to NYSE in APRIL 2022




GO $ZTEK

ZENYF changed to ZTEK. Moved to the Nasdaq from the OTC:

https://otce.finra.org/otce/dailyList?viewType=Deletions

https://www.sec.gov/Archives/edgar/data/1904501/000106299322008179/exhibit99-1.htm

So, what’s “graduation day” going to bring ? Something good I hope !

I hate this short shit….
March 8, 2022

Zentek Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions has become aware of certain rumours and allegations being circulated, and categorically refutes the egregious allegation regarding the theft of intellectual property from Graphene Composites Ltd.
On January 29, 2021, the Company was served with a statement claim issued by Graphene Composites Ltd. and is in the process of defending the action, which it considers frivolous and without merit. The Company has considered the allegations as set out in the claim and, in light of the facts, the lack of clarity in the claim, and, based on discussions with the Company’s litigation counsel, the assessment of the merits of the claim and the defenses available to the Company, and the Company’s conclusion is that the risk of the Company suffering loss in respect of the claim is remote, and therefore the Company determined the claim not to be material or constituting ”significant litigation” pursuant to the policies of the TSX Venture Exchange. The Company continues to view this claim as frivolous and will continue to vigorously defend itself against these allegations.

The Company is aware of a 2,904,839 share Consolidated Short Position (less than 3% of total shares outstanding) in the marketplace as of March 1, 2022. Furthermore, the Company believes these false allegations were meant to hurt the Company’s credibility.

Short report on Zentek

Says previous partner claims Zentek stole its technology. also claims masks won't sell.

ZENTK, movin uptown !!!